2023 Annual Meeting | P1 - Poster Session 01

Date Sunday 04/23/23

Time 08:00 AM - 09:00 AM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Sleep, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, ��ɫ��, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-ophthalmology/Neuro-otology, Neuro Trauma and Critical Care

CME Available 0.00 CME credit

Event Timeline
08:00 AM - 09:00 AM EST	Abstract	9-001 - Assessing Neuropsychology Testing Variation at Level IV Epilepsy Centers Patrick Landazuri, MD, FAAN
08:00 AM - 09:00 AM EST	Abstract	9-002 - Short versus Long video-EEG in Diagnosis of Psychogenic Non-Epileptic Spells (PNES): Yield and Cost-Effectiveness Haneen F. Al Refa'i
08:00 AM - 09:00 AM EST	Abstract	9-004 - Feasibility and Insights from Automated Depression and Anxiety Screening for People with Epilepsy Lilian Maria Godeiro Coelho, MD
08:00 AM - 09:00 AM EST	Abstract	9-005 - Correlation Between Depressive And Anxious Symptoms And White Matter Changes In Relatives Of People With Epilepsy Gabriel F. Baltazar
08:00 AM - 09:00 AM EST	Abstract	9-006 - Association of interictal EEG findings in those with concomitant epileptic seizures and PNES Gabriela Alejo, MD
08:00 AM - 09:00 AM EST	Abstract	9-008 - Improving Post-Operative Psychiatric Outcomes in Surgical Epilepsy Patients Tandees Najimi
08:00 AM - 09:00 AM EST	Abstract	9-009 - Epileptiform Discharges in Patients with Psychogenic Non-Epileptic Attacks: A Case Series Mohamed Afify, MD
08:00 AM - 09:00 AM EST	Abstract	9-011 - Investigation of anxiety, depression, and adjustment disorder in mothers of children with a seizure disorder in the Georgian population Mariam Alavidze
08:00 AM - 09:00 AM EST	Abstract	15-001 - Assessing a Novel Asynchronous EEG-Learning Curriculum via Quantitative and Qualitative Methods Christopher B. Traner, MD
08:00 AM - 09:00 AM EST	Abstract	15-002 - A Longitudinal Experience and Annual “Check-Ins” to Increase Resident EEG and EMG Milestone Attainment and Improve Milestone Rating Accuracy Harry Sutherland, MD
08:00 AM - 09:00 AM EST	Abstract	15-003 - Neuropalliative Curriculum in Neurology Residency Program Gitanjali Das, MD
08:00 AM - 09:00 AM EST	Abstract	15-004 - Teaching Neurology Trainees to Provide a Terminal Diagnosis Using Objective Structured Clinical Examinations (OSCE) Mordechai Z. Smith, MD
08:00 AM - 09:00 AM EST	Abstract	15-005 - Assessing the Impact of a Multi-Modal Neuro-Ophthalmology ��ɫ��al Workshop on Resident Confidence in the Neuro-Ophthalmology Examination Jieun Kang, MD
08:00 AM - 09:00 AM EST	Abstract	15-006 - An Interactive Approach to Teaching Neurology Residents about Intellectual and Developmental Disabilities (IDD): Effects of In-Person Versus Virtual Noon Conferences Julia S. Frueh, MD
08:00 AM - 09:00 AM EST	Abstract	3-001 - Cerebrospinal Fluid Biomarkers Associated with Intrathecal Cell Therapy in Patients with Progressive Multiple Sclerosis Cara Kizilbash
08:00 AM - 09:00 AM EST	Abstract	3-002 - Serum Natalizumab and Anti-Natalizumab Antibody Concentrations May Be Useful in Patient Management
08:00 AM - 09:00 AM EST	Abstract	3-003 - Plasma glial fibrillary acidic protein levels correlate with unfavourable imaging measures in Radiologically Isolated Syndrome Raphael Schneider, MD
08:00 AM - 09:00 AM EST	Abstract	3-005 - Establishing Demographic and Comorbidity Based Reference Ranges for NfL and GFAP in Healthy Controls Tyler L. Borko, BA
08:00 AM - 09:00 AM EST	Abstract	3-006 - Serum NfL in MS Patients Treated with Cladribine: Course and Predictive Value Tobias Moser
08:00 AM - 09:00 AM EST	Abstract	3-007 - A Systematic Review of Epstein-Barr Virus Antibodies as Clinical Biomarkers in Multiple Sclerosis Abigail S. Bose, MD
08:00 AM - 09:00 AM EST	Abstract	3-008 - Identification of multiple sclerosis endophenotypes by high dimensional blood signatures associated with distinct disease trajectories Luisa H. Klotz, MD
08:00 AM - 09:00 AM EST	Abstract	3-009 - Serum Neurofilament Light Chain Levels as a Biomarker of Disease Activity and Treatment Response in Patients with Progressive and Relapsing Multiple Sclerosis Marzena Pedrini, PhD
08:00 AM - 09:00 AM EST	Abstract	3-010 - Using Plasma NfL and GFAP to Monitor Response to Anti-CD20 Treatment in MS Robert H. Gross, MD, FAAN
08:00 AM - 09:00 AM EST	Abstract	3-011 - Neurofilament Light Chain Levels and Disease Activity During Long-Term Treatment of Relapsing Multiple Sclerosis with the Bruton's Tyrosine Kinase Inhibitor Evobrutinib Ludwig Kappos, MD, FAAN
08:00 AM - 09:00 AM EST	Abstract	3-012 - NfL as a Predictor of GdE Lesions in Patients With Relapsing Multiple Sclerosis Treated With Ozanimod in the Phase 2 RADIANCE Trial Sarah Harris
08:00 AM - 09:00 AM EST	Abstract	3-013 - Relevance of Bright Spotty Lesions (BSLs) in Neuromyelitis Optica Spectrum Disorders (NMOSD): A Case Series Katherine E. Beard, MD
08:00 AM - 09:00 AM EST	Abstract	3-014 - Role Of Antimüllerian Hormone Levels and Neurofilament Light Chains In Family Planning In MS Juan Pablo Cuello
08:00 AM - 09:00 AM EST	Abstract	12-001 - Patient Experience with Video Telemedicine Neurology Follow-up Visits at Community Clinics Karen Truitt, DO
08:00 AM - 09:00 AM EST	Abstract	12-002 - Teleneurology Satisfaction during the COVID-19 Pandemic
08:00 AM - 09:00 AM EST	Abstract	12-003 - Patient Satisfaction with Teleneurology across Neurologic Conditions Courtney Seigel, MD
08:00 AM - 09:00 AM EST	Abstract	12-004 - The Lacune of Teleneurology: Autochromatic Correction of Jaundice Sunjeet Brar
08:00 AM - 09:00 AM EST	Abstract	12-005 - Bilateral Subdural Hematoma, The Cause or Consequence Narmada Mannem, MBBS
08:00 AM - 09:00 AM EST	Abstract	12-006 - Intravenous tPA administration in patients with negative diffusion-weighted imaging (DWI) study on the MRI brain Pradeepthi Badugu, MBBS
08:00 AM - 09:00 AM EST	Abstract	12-007 - Correlation analysis of parameters of cardiointervalography and immune status in patients with ischemic stroke depending on the affected area Nargiza Chekeeva
08:00 AM - 09:00 AM EST	Abstract	6-001 - Overview of the Safety Profile from Efgartigimod Clinical Trials in Participants with Diverse IgG-Mediated Autoimmune Diseases Kelly G. Gwathmey, MD
08:00 AM - 09:00 AM EST	Abstract	6-002 - Change in Concomitant Therapies for Generalized Myasthenia Gravis in Patients Receiving Eculizumab: a Retrospective Analysis of Registry Data Michael T. Pulley, MD, PhD, FAAN
08:00 AM - 09:00 AM EST	Abstract	6-003 - Comorbidities in patients with myasthenia gravis in the USA: a retrospective claims database analysis Raj Bandaru
08:00 AM - 09:00 AM EST	Abstract	6-004 - Ravulizumab for the Treatment of Generalized Myasthenia Gravis: Timing of Response Ali A. Habib, MD
08:00 AM - 09:00 AM EST	Abstract	6-005 - Investigating Autoantibody Profiles in Seronegative Myasthenia Gravis Gianvito Masi, MD
08:00 AM - 09:00 AM EST	Abstract	6-006 - Subgroup outcomes from RAISE: A randomized, Phase 3 trial of zilucoplan in generalized myasthenia gravis Michael D. Weiss, MD, FAAN
08:00 AM - 09:00 AM EST	Abstract	6-007 - RAISE-XT: An interim analysis of safety and efficacy in an open-label extension study of zilucoplan in patients with myasthenia gravis Miriam L. Freimer, MD, FAAN
08:00 AM - 09:00 AM EST	Abstract	6-008 - Study design and methodology of the PREVAIL trial: a phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of subcutaneous ALXN1720 in adults with generalized myasthenia gravis James F. Howard, Jr., MD, FAAN
08:00 AM - 09:00 AM EST	Abstract	6-009 - A Rare Case of Thymoma-Associated Idiopathic Inflammatory Myopathy and Myasthenia Gravis Chelsea Schmoll, DO
08:00 AM - 09:00 AM EST	Abstract	6-010 - Mortality in Mechanically Ventilated Myasthenia Gravis Adult Patients: Comparing Intravenous Immunoglobulin vs Steroids Kranthi K. Mandava
08:00 AM - 09:00 AM EST	Abstract	6-011 - Use of Efgartigimod in Treatment of Myasthenia Gravis Relapse after Possible Recurrence of Invasive Thymoma: A Case Report. Elif P. Coskun, MD
08:00 AM - 09:00 AM EST	Abstract	6-012 - Long-term Efficacy and Safety of Symptom-driven Cyclic Rozanolixizumab Treatment in Patients with Generalized Myasthenia Gravis: A Pooled Analysis of a Phase 3 Study and Two Open-label Extension Studies John Vissing, MD
08:00 AM - 09:00 AM EST	Abstract	6-013 - Ravulizumab in Adults with Generalized Myasthenia Gravis: A Sub-Analysis of the Phase 3 CHAMPION MG Study According to Chronic IVIg Use at Study Entry Glen Frick, MD, PhD
08:00 AM - 09:00 AM EST	Abstract	6-014 - Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC+ Study James F. Howard, Jr., MD, FAAN
08:00 AM - 09:00 AM EST	Abstract	6-015 - Efgartigimod Demonstrates Consistent Improvements in Generalized Myasthenia Gravis Patients of Shorter Disease Duration Edward Brauer
08:00 AM - 09:00 AM EST	Abstract	6-016 - Safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of subcutaneous and intravenous ALXN1720 in healthy volunteers: a phase 1, randomized, double-blind, placebo-controlled, single and multiple ascending dose study Stephan Ortiz, PhD
08:00 AM - 09:00 AM EST	Abstract	6-017 - Dose Selection and Clinical Development of Efgartigimod PH20 Subcutaneous in Patients with Generalized Myasthenia Gravis Jenna Casey
08:00 AM - 09:00 AM EST	Abstract	6-018 - Nipocalimab Dose Selection for A Phase 3 Study in Adult Patients with Generalized Myasthenia Gravis Yaowei Zhu, PhD
08:00 AM - 09:00 AM EST	Abstract	6-019 - Post COVID-19 Myasthenia Gravis Nathaniel P. Rogers, Jr., MD
08:00 AM - 09:00 AM EST	Abstract	6-020 - Myasthenia Gravis Activities of Daily Living (MG-ADL) Response to Eculizumab Treatment in Patients from the Generalized Myasthenia Gravis Registry Ericka P. Greene, MD, FAAN
08:00 AM - 09:00 AM EST	Abstract	6-021 - Insomnia Symptoms Trajectories and increased risk of Stroke: A Prospective Cohort Study Wendemi Sawadogo
08:00 AM - 09:00 AM EST	Abstract	6-022 - Impact of Insurance on Acute Stroke Care Cost: A mediation analysis Andrew M. Southerland, MD, FAAN
08:00 AM - 09:00 AM EST	Abstract	6-023 - Effect of SARS-CoV-2 Pandemic on Trends in Stroke Hospitalizations and Associated Risk Factors in Non-SARS-CoV-2 Infection Patients Mohsen Ahmed
08:00 AM - 09:00 AM EST	Abstract	6-024 - Data in brief: Factors associated with in-patient admission among stroke patients Jared C. Wolfe, MD
08:00 AM - 09:00 AM EST	Abstract	6-026 - Substance Use, Demographics, and Other Medical Diagnoses That Increase Readmission Rates After Stroke Christina Istrate, MD
08:00 AM - 09:00 AM EST	Abstract	6-027 - Association Between TBI Exposure and Multiple Sclerosis Among Post-9/11 Era Veterans Mary Jo Pugh, PhD, RN, FAAN
08:00 AM - 09:00 AM EST	Abstract	6-028 - Addressing The Traumatic Brain Injury Crisis In Thailand: Analysis Of National Access To Neurosurgical Facilities Utilizing Geospatial Mapping Arnav Mahajan
08:00 AM - 09:00 AM EST	Abstract	6-029 - Sex Differences in Characteristics and Outcomes of Patients with Todd’s Paralysis; An Analysis From 11,175 Cases in the United States Shaheen Sombans, MBBS
08:00 AM - 09:00 AM EST	Abstract	6-030 - Survival Analysis Methods in Natural History Studies Alex Berger, BS
08:00 AM - 09:00 AM EST	Abstract	6-031 - Regional Epidemiology of Status Epilepticus: Determinants for Healthcare Cost and Outcome in Central New York Yung-Tian Gau, MD, PhD
08:00 AM - 09:00 AM EST	Abstract	6-032 - Predictors of No-show in Neurology clinics Thirumalaivasan Dhasakeerthi, MBBS
08:00 AM - 09:00 AM EST	Abstract	7-001 - Cdk5 inhibition in the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis suppresses neurodegeneration and extends survival. Ahwon Kim, MD
08:00 AM - 09:00 AM EST	Abstract	7-002 - Hexanucleotide repeat expansions in C9orf72 alter microglial responses and prevent a coordinated glial reaction in ALS Pegah Masrori, MD
08:00 AM - 09:00 AM EST	Abstract	7-003 - RACK1 Knockdown is a Potential Therapeutic Target in ALS and FTLD-TDP Neil Cashman, MD
08:00 AM - 09:00 AM EST	Abstract	7-004 - Aqueously diffusible RNA-bound amyloid-ß aggregates in Alzheimer disease brain Andrew Stern, MD
08:00 AM - 09:00 AM EST	Abstract	7-005 - Single-cell RNA analysis reveals cell-specific increases in SUR1-related pathway activity with age in murine brain.
08:00 AM - 09:00 AM EST	Abstract	7-006 - Protection against toxic amyloid-beta oligomers by PMN310, a monoclonal antibody rationally designed for greater therapeutic potency in Alzheimer’s disease Johanne M. Kaplan, PhD
08:00 AM - 09:00 AM EST	Abstract	7-007 - A Lipopolysaccharide Mouse Model Mirrors Neuroinflammatory Transcriptional Signatures of Human AD, and the Glucagon-Like Peptide-1 Receptor Agonist Semaglutide Attenuates Neuroinflammation in this Model Christian Wichmann
08:00 AM - 09:00 AM EST	Abstract	7-008 - Microbiota-derived SCFAs Promote Chronic Neurogenesis and Anti-inflammatory Gene Expression after Traumatic Brain Injury
08:00 AM - 09:00 AM EST	Abstract	7-009 - Optogenetic activation of basal forebrain cholinergic neurons improves interval timing performance in rodents Qiang J. Zhang, MD
08:00 AM - 09:00 AM EST	Abstract	7-010 - Assessing the Co-Chaperone and Synaptic Protein DNAJC5 as a Therapeutic Target in Alzheimer’s Disease Matthew J. Rosene, PhD
08:00 AM - 09:00 AM EST	Abstract	1-001 - Neuroprognostication After Out of Hospital Asystole Cardiac Arrest Trilok Stead
08:00 AM - 09:00 AM EST	Abstract	1-002 - Predictors of Good Neurologic Outcome After Pulseless Electrical Activity Latha Ganti, MD, MS, MBA, FACEP
08:00 AM - 09:00 AM EST	Abstract	1-004 - Isolated Brainstem Death is Rare and is Associated with Infratentorial Stroke Among Patients Suspected of Death by Neurologic Criteria Joel Neves Briard, MD
08:00 AM - 09:00 AM EST	Abstract	1-005 - Efficacy of the Implementation of Brain Herniation Codes at a Tertiary Medical Center Eunice J. Lee, MD
08:00 AM - 09:00 AM EST	Abstract	1-006 - Eye Movement and Coma Recovery after Cardiac Arrest Michael F. Cronin
08:00 AM - 09:00 AM EST	Abstract	10-001 - A case report of resolving an uncertain variant in CHRN1B as pathogenic leading to Congenital Myasthenic Syndrome type 2C. Zurisadai Gonzalez, MD
08:00 AM - 09:00 AM EST	Abstract	10-002 - Triple M Syndrome with Triple Seronegative Myasthenia Gravis presenting as a Non-ST Elevation Myocardial Infarction Octavio Carranza-Renteria, MD
08:00 AM - 09:00 AM EST	Abstract	10-004 - Clinical Experience With Efgartigimod For Treatment Of Acetylcholine Receptor Antibody Positive Generalized Myasthenia Gravis Nakul Katyal, MD
08:00 AM - 09:00 AM EST	Abstract	10-005 - Malignant Ectopic Cervical Thymoma in Myasthenia Gravis: A Case Report Shima Zargar, MD
08:00 AM - 09:00 AM EST	Abstract	10-006 - Efgartigimod for Pembrolizumab-induced Myasthenia Gravis Refractory to Standard Therapy Zufe Rizvi, MD
08:00 AM - 09:00 AM EST	Abstract	10-007 - The impact of Myasthenia Gravis antibody status on pregnancy and neonatal outcomes Mariam a. Al Hussona, MB BCh BAO
08:00 AM - 09:00 AM EST	Abstract	10-008 - Acquired Rippling Muscle Disease with Acetylcholine Receptor Antibodies Thapat Wannarong, MD
08:00 AM - 09:00 AM EST	Abstract	10-009 - Characterization of Early Adopters of Efgartigimod for gMG Emma McFadden, PhD
08:00 AM - 09:00 AM EST	Abstract	10-010 - Iron Metabolism Patterns in Non-anemic Myasthenia Gravis Patients: A Cross-sectional and Follow-up Study Ke Li, MD
08:00 AM - 09:00 AM EST	Abstract	10-011 - Benefit of Neuromuscular Ultrasound on Patient Management and Outcomes Raed Gasemaltayeb, MD
08:00 AM - 09:00 AM EST	Abstract	10-012 - Utility of Diagnostic Neuromuscular Ultrasound in Unrevealing Electrodiagnostic Studies: Case Series Eonjung Kim, MD
08:00 AM - 09:00 AM EST	Abstract	10-013 - Four Looks to a Gene Narges Rahimi, MD
08:00 AM - 09:00 AM EST	Abstract	10-015 - Validation of the Toronto Cramp Impact Index (TCII) for Assessment of Muscle Cramps Hans D. Katzberg, MD, FAAN
08:00 AM - 09:00 AM EST	Abstract	4-001 - Orbital Myositis Presenting as a Late Immune-Related Adverse Event Four Months After Stopping Immune Checkpoint Inhibitor Mohammad Dibs, MD
08:00 AM - 09:00 AM EST	Abstract	4-004 - A Case of Neural Integrator Failure in Vitamin B1 Deficiency. Hongying Chen, MB BCh BAO
08:00 AM - 09:00 AM EST	Abstract	4-006 - Horner’s Syndrome as an Atypical Presentation of Neuroborreliosis: A Case Report and Review of Literature Sarah Bou Reslan, MD
08:00 AM - 09:00 AM EST	Abstract	4-007 - A Rare Case of Bilateral Optic Perineuritis, Scleritis and Uveitis in a Pediatric Patient Following Influenza Vaccination Nathaniel G. Wooten, MD
08:00 AM - 09:00 AM EST	Abstract	4-008 - Bilateral Ischemic Optic Neuropathy as the First Manifestation of Severe Anemia Sayyeda Zahra, MD
08:00 AM - 09:00 AM EST	Abstract	4-010 - When vision loss is beyond cataract: a case of fatal neurodegenerative disease Khawla M. Abusamra, MBBS
08:00 AM - 09:00 AM EST	Abstract	4-011 - Visual hallucinations. More than just a psychiatric problem. Muhammad S. Bhatti, MD
08:00 AM - 09:00 AM EST	Abstract	4-012 - Curious Cases of Painful Ophthalmoplegia Keshav J. Shah, MBBS
08:00 AM - 09:00 AM EST	Abstract	13-001 - Pitfalls in the diagnosis of Cryptococcal Meningoencephalitis. Yash Nene, MBBS
08:00 AM - 09:00 AM EST	Abstract	13-002 - Bruton Tyrosine Kinase Inhibitor Associated Cryptococcal Meningitis Manifesting as Stroke Michael A. Perez, MD
08:00 AM - 09:00 AM EST	Abstract	13-003 - A Case of Brainstem Cryptococcoma Causing Pontine Stroke in an Immunocompetent Male Iffat Jabeen, MD
08:00 AM - 09:00 AM EST	Abstract	13-004 - Cryptococcal Cerebellitis In the Setting of Fingolimod Use for Multiple Sclerosis: Atypical Clinical Presentation of Dystonia and Imaging Finding Mimicking Subacute Ischemic Stroke Raman Singh, MD, MBBS
08:00 AM - 09:00 AM EST	Abstract	13-005 - Cryptococcal Meningoencephalitis and Immune Reconstitution Inflammatory Syndrome in a patient on Tocilizumab Therapy: A Case Report Nina Navalkar, MD
08:00 AM - 09:00 AM EST	Abstract	13-006 - Atypical Presentation of Nocardia Brainstem Abscess: A Case Report Sathvik S. Shastry, MD
08:00 AM - 09:00 AM EST	Abstract	13-007 - Bacterial Meningitis, Streptococcus Suis Isolate: A Case Series Wilgee Eila S. Abbot, MD
08:00 AM - 09:00 AM EST	Abstract	5-001 - A Double-Blind, Sham Controlled Study of Transcranial Photobiomodulation (PBM) in Parkinsons Disease Geoffrey K. Herkes, MBBS, PhD, FRACP
08:00 AM - 09:00 AM EST	Abstract	5-002 - Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease: ADAPT-PD clinical trial methodology and early data Todd Herrington, MD
08:00 AM - 09:00 AM EST	Abstract	5-003 - Foslevodopa/foscarbidopa Subcutaneous Infusion Maintains Similar Levodopa Exposure to Levodopa-Carbidopa Intestinal Gel Delivered to the Jejunum when Infused for 24-hours Matthew Rosebraugh, PhD
08:00 AM - 09:00 AM EST	Abstract	5-004 - Design and Baseline characteristic of Phase II clinical trial of allogeneic bone marrow-derived Mesenchymal Stem Cells as a disease-modifying therapy for idiopathic Parkinson’s disease Mya C. Schiess, MD, FAAN
08:00 AM - 09:00 AM EST	Abstract	5-005 - Randomized, waitlist-controlled trial of KICK OUT PD: Parkinson’s Disease-specific karate yields high adherence and improved quality of life Joshua Chodosh, MD
08:00 AM - 09:00 AM EST	Abstract	5-006 - Integrated safety summary from Phase 3 clinical trials of IPX203, an extended-release carbidopa-levodopa formulation, in Parkinson disease Hubert H. Fernandez, MD, FAAN
08:00 AM - 09:00 AM EST	Abstract	5-007 - Reducing a-Synuclein in Human CSF; An Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEDI1341, an a-Synuclein-specific antibody, in Healthy Volunteers and Parkinson’s Disease Patients Craig Shering, Other
08:00 AM - 09:00 AM EST	Abstract	5-008 - Safety, Tolerability, And Efficacy Of NE3107 From A Phase 2, Double-Blind, Placebo-Controlled Study In Levodopa/Carbidopa-Treated Patients With Parkinson's Disease
08:00 AM - 09:00 AM EST	Abstract	5-009 - Racial and Ethnic Disparities in Access to Huntington’s Disease (HD) care in North America: Analysis using the ENROLL-HD dataset Adys Mendizabal, MD, MS
08:00 AM - 09:00 AM EST	Abstract	5-010 - Chorea Severity Change Over Time in Huntington Disease and by Huntington Disease Stage Nayla Chaijale
08:00 AM - 09:00 AM EST	Abstract	5-011 - Randomized Trial of Telegenetic Counseling for Gene Testing in Huntington’s Disease Deborah H. Hall, MD, PhD, FAAN
08:00 AM - 09:00 AM EST	Abstract	5-012 - The Risk of Depression in a Large Huntington Disease Population Compared With Controls: Analysis of the Enroll-HD Registry Data Nayla Chaijale
08:00 AM - 09:00 AM EST	Abstract	5-013 - Melatonin for Huntington Disease (HD) Gene Carriers with HD-Related Sleep Disturbance - a Pilot Study Jorge E. Patino Murillas, MD
08:00 AM - 09:00 AM EST	Abstract	5-014 - Prevalence of Neurocognitive Disorder in a Pre-manifest Huntington’s disease Cohort Luis A. Sierra, Jr.
08:00 AM - 09:00 AM EST	Abstract	5-015 - Molecular Gene Expression Analysis of Medium Spiny Neurons in Huntington’s Disease Evan El-Halawani
08:00 AM - 09:00 AM EST	Abstract	5-016 - Investigating the Effects of Brain Cholesterol Metabolism Using CYP46A1 Gene Therapy in Subjects with Huntington’s Disease Meredith Schultz, MD
08:00 AM - 09:00 AM EST	Abstract	2-001 - “Klüver-Bucy syndrome as a complication of COVID-19” Nigar Dargah-Zada, MD
08:00 AM - 09:00 AM EST	Abstract	2-003 - Cerebral amyloid angiopathy-related inflammation (CAARI) and HHV-6 positivity: A case report of a treatment dilemma and a possible relationship Anas Alshawa, MD
08:00 AM - 09:00 AM EST	Abstract	2-004 - A Scoping Review of Functional Neurological Disorder in Sexual and Gender Minority People Valeria Roldan
08:00 AM - 09:00 AM EST	Abstract	2-005 - Establishing the relationship between ADHD and emotional facial expression recognition deficit: a systematic review Maria D. Olaya Galindo, MD
08:00 AM - 09:00 AM EST	Abstract	2-006 - A Survey of Virtual Reality Interventions for Autistic Spectrum Disorder Therapy: A Neuroscience Perspective Dana Allison
08:00 AM - 09:00 AM EST	Abstract	2-007 - Identifying Key Patterns of Social and Structural Determinants of Health and Their Association with Dementia Risk in a Population-Based Study of Cognitive Aging Maria Vassilaki, MD, PhD
08:00 AM - 09:00 AM EST	Abstract	2-008 - CD5 knockout modulates effects of alcohol consumption in mouse models Alfred B. Amendolara, Jr., MD
08:00 AM - 09:00 AM EST	Abstract	2-009 - Norepinephrine Regulates Spatial Memory Consolidation Using Barnes Maze in Male, but Not Female Rats Serena Simpson, MD
08:00 AM - 09:00 AM EST	Abstract	2-010 - Prevalence, demographics and etiologies of early-onset dementia in Brazil: a retrospective cohort Joao Vitor Mahler, MD
08:00 AM - 09:00 AM EST	Abstract	11-001 - Evaluation of Sleep Parameters with Polysomnography and Multiple Sleep Latency Test in Cirrhotic Patients with Daytime Sleepiness Kadriye Agan
08:00 AM - 09:00 AM EST	Abstract	11-002 - Untreated Moderate-to-Severe Sleep-Related Breathing Disorders Are Associated with Increased Frequency of Episodes of Autonomic Dysreflexia during Sleep in Individuals with Subacute or Chronic Spinal Cord Injury: A Prospective Cross-Sectional Study. Julio C. Furlan, MD, PhD, MBA, MSc, FAAN
08:00 AM - 09:00 AM EST	Abstract	11-003 - Brain Age Prediction based on Sleep EEG in Shift Workers Su Jung Choi, PhD, RN
08:00 AM - 09:00 AM EST	Abstract	11-004 - Sleep Duration is Associated with Clinically Silent Brain Injury in Middle-Aged Persons without Stroke Santiago Clocchiatti-Tuozzo
08:00 AM - 09:00 AM EST	Abstract	11-005 - Insomnia and Post Acute Sequelae of COVID-19 in an outpatient neurology cohort Sherry Fung

Faculty Disclosures
	No disclosure on file
Claudia Talero-Gutierrez	Dr. Talero-Gutierrez has nothing to disclose.
Perrin A. Pleninger, MD, FAAN	Dr. Pleninger has nothing to disclose.
Sujata P. Thawani, MD	Dr. Thawani has nothing to disclose.
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Nicole Rosendale, MD, FAAN	Dr. Rosendale has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Rosendale has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Rosendale has received research support from ��ɫ��. The institution of Dr. Rosendale has received research support from NIH StrokeNet Fellowship. The institution of Dr. Rosendale has received research support from The Dana Foundation. The institution of Dr. Rosendale has received research support from UArizona-Banner All of Us Seed Grant. Dr. Rosendale has received publishing royalties from a publication relating to health care.
Kavita Nair, PhD, FAAN	Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MJH Lifesciences. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Patient Experience. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MHJ Life Sciences. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for ICER. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS. The institution of Dr. Nair has received research support from Sanofi Genzyme. The institution of Dr. Nair has received research support from Kyverna Therapeutcis. Dr. Nair has a non-compensated relationship as a Board Member with Center for Improving Value in Healthcare that is relevant to AAN interests or activities.
John Corboy, MD, FAAN	Dr. Corboy has received personal compensation for serving as an employee of U of Coloado. Dr. Corboy has received personal compensation for serving as an employee of Rocky Mountain MS Center. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mylan. Dr. Corboy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Mylan. The institution of Dr. Corboy has received research support from MedDay. The institution of Dr. Corboy has received research support from Novartis. The institution of Dr. Corboy has received research support from NMSS. The institution of Dr. Corboy has received research support from PCORI. The institution of Dr. Corboy has received research support from EMD Serono.
Ariane Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Sunjeet Brar	Miss Brar has nothing to disclose.
Anas Alshawa, MD	Dr. Alshawa has nothing to disclose.
Mariam Alavidze	Miss Alavidze has nothing to disclose.
Craig Shering, Other	Dr. Shering has received personal compensation for serving as an employee of AstraZeneca. An immediate family member of Dr. Shering has received personal compensation for serving as an employee of eResearch Technology Inc. Dr. Shering has stock in AstraZeneca. Dr. Shering has received intellectual property interests from a discovery or technology relating to health care.
Vern C. Juel, MD, FAAN	Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. The institution of Dr. Juel has received research support from argenx. The institution of Dr. Juel has received research support from Alexion. The institution of Dr. Juel has received research support from Janssen. The institution of Dr. Juel has received research support from NIH Rare Diseases Network.
Raphael Schneider, MD	Dr. Schneider has nothing to disclose.
Stefan Sillau	Stefan Sillau has nothing to disclose.
Tarek E. Ali, MBBS	Dr. Ali has nothing to disclose.
Emma Yellin, MD	Dr. Yellin has nothing to disclose.
Samir P. Macwan, MD	Dr. Macwan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion,Argenx,Grifols,Kabafusion, UCB. Dr. Macwan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie,Alexion,Argenx,Grifols and UCB. The institution of Dr. Macwan has received research support from Alexion, Argenx,Immunovant, UCB.
Jeffrey L. Bennett, MD, PhD, FAAN	Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immpact Bio. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIAC. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Bennett has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vindico. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Touch IME. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Efficient LLC. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pavich. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Marie Bush. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marks Gray. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Knight, Nicastro, MacKay. The institution of Dr. Bennett has received research support from Alexion. The institution of Dr. Bennett has received research support from Genentech. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Jiwon Oh, MD, FAAN	Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Oh has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Oh has received research support from Biogen-Idec. The institution of Dr. Oh has received research support from Roche.
Patrick Landazuri, MD, FAAN	Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Federal Public Defender - District of Kansas. Dr. Landazuri has received publishing royalties from a publication relating to health care.
Arielle M. Kurzweil, MD, FAAN	Dr. Kurzweil has nothing to disclose.
Jorge E. Patino Murillas, MD	Dr. Patino Murillas has nothing to disclose.
James E. Siegler III, MD	Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siegler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serb. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wallaby Phenox. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Precision Medicine, LLC. The institution of Dr. Siegler has received research support from Philips. The institution of Dr. Siegler has received research support from Medtronic.
Sonia Brucki	Sonia Brucki has nothing to disclose.
Sophie Steeland	Sophie Steeland has received personal compensation for serving as an employee of argenx. Sophie Steeland has stock in argenx.
Abigail S. Bose, MD	Dr. Bose has nothing to disclose.
Anna Castillo	Anna Castillo has nothing to disclose.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Ace Adamson, PhD	Dr. Adamson has nothing to disclose.
Kazim Jaffry	Mr. Jaffry has nothing to disclose.
Lawrence J. Hirsch, MD, FAAN	Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker; Faculty for Fellows' training course with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus.
David M. Greer, MD, FAAN	Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has a non-compensated relationship as a Treasurer-Elect with American Neurological Association that is relevant to AAN interests or activities. Dr. Greer has a non-compensated relationship as a President with Neurocritical Care Society that is relevant to AAN interests or activities.
Andrew M. Southerland, MD, FAAN	Dr. Southerland has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Plaintiffs and Defense Cases related to Stroke and Vascular Neurology.. The institution of Dr. Southerland has received research support from American Heart Association. The institution of Dr. Southerland has received research support from NIH. The institution of Dr. Southerland has received research support from Abbvie Pharmaceuticals, Inc.. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care.
Z P. L'Erario, MD, LMSW	Dr. L'Erario has received publishing royalties from a publication relating to health care.
Robert H. Gross, MD, FAAN	Dr. Gross has nothing to disclose.
Guido J. Falcone, MD	The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
Lilian Maria Godeiro Coelho, MD	Dr. Godeiro Coelho has nothing to disclose.
Thomas M. Hyde, MD, PhD	Dr. Hyde has received personal compensation for serving as an employee of Lieber Institute for Brain Development. The institution of Dr. Hyde has received research support from National Institutes of Health.
Benjamin Van Hoorick	Dr. Van Hoorick has received personal compensation for serving as an employee of argenx. Dr. Van Hoorick has stock in argenx.
Marc Dinkin, MD	Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bush Graziano Rice & Platter, P.A.. Dr. Dinkin has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Luks, Santiello. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Luks and Santaniello. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dughi, Hewit & Domalewski, PC.
Deborah H. Hall, MD, PhD, FAAN	Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from NIH.
Laura J. Balcer, MD, MSCE, FAAN	An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Neepa J. Patel, MD, FAAN	Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie Pharmaceuticals. Dr. Patel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernius Pharmaceuticals. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Ahwon Kim, MD	Dr. Kim has nothing to disclose.
Hannah Shapiro, MD	The institution of Dr. Shapiro has received research support from Pfizer. The institution of Dr. Shapiro has received research support from PCORI.
Krishna Nalleballe, MD, FAAN	Dr. Nalleballe has nothing to disclose.
Melanie Guenette	No disclosure on file
Shahram Attarian, MD, PhD	Prof. Attarian has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI, Pfizer LFB, Alnylam Biogen Argenx, UCB Alexion, Astrazenica, Amicus, Janssen, Novartis, Roche. Prof. Attarian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SANOFI, Biogen,Alnylam, Argenx, USB, Alexion Astrazenica, Janssen, Roche, Amgen. The institution of Prof. Attarian has received research support from National Institut of Health .
Carolina Cuello-Oderiz, MD	Dr. Cuello-Oderiz has nothing to disclose.
Laura Istrate, MD	Dr. Paul has nothing to disclose.
John E. Paddock, MD	Dr. Paddock has nothing to disclose.
Susan T. Herman, MD, FAAN	The institution of Dr. Herman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioserenity. Dr. Herman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for National Association of Epilepsy Centers. Dr. Herman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Treatment Options in Neurology. Dr. Herman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. The institution of Dr. Herman has received research support from Epilepsy Foundation; Epilepsy Learning Healthcare System. The institution of Dr. Herman has received research support from CREMedical. The institution of Dr. Herman has received research support from NIH/NINDS. The institution of Dr. Herman has received research support from Marinus. The institution of Dr. Herman has received research support from Neuroelectrics, Inc. Dr. Herman has received personal compensation in the range of $500-$4,999 for serving as a Medical Director, Neurodiagnostics Program with Laboure College. Dr. Herman has a non-compensated relationship as a Professional Advisory Board member with Epilepsy Foundation that is relevant to AAN interests or activities.
Srikanth Muppidi, MD, FAAN	Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J & J pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Lidia Maria V. Moura, MD, PhD, MPH, FAAN	Dr. Moura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Moura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Moura has received research support from Centers for Diseases Control and Prevention (CDC SIP20-007) . The institution of Dr. Moura has received research support from Epilepsy Foundation of America . The institution of Dr. Moura has received research support from NIH - NIA and NINDS. Dr. Moura has received personal compensation in the range of $50,000-$99,999 for serving as a Expert Advisor with Epilepsy Foundation .
Jonathan Graff-Radford, MD, FAAN	Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD .
David S. Knopman, MD, FAAN	Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Sasha Alick-Lindstrom, MD, MPH FACNS, FAES, FAAN	Dr. Alick-Lindstrom has nothing to disclose.
Aileen Antonio, MD, FAAN	Dr. Antonio has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cochrane. An immediate family member of Dr. Antonio has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Giamarco, Mullins & Horton PC. The institution of Dr. Antonio has received research support from Saint Mary's Foundation. Dr. Antonio has received research support from ��ɫ��.
Jeffrey Dewey, MD, MHS, FAAN	Dr. Dewey has received personal compensation in the range of $500-$4,999 for serving as a Expert Medication Request Reviewer with Megallan.
Jill L. Ostrem, MD, FAAN	Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz . Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Superness. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AcureX. Dr. Ostrem has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspen. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Ostrem has received research support from Neuroderm. The institution of Dr. Ostrem has received research support from Boston Scientific. The institution of Dr. Ostrem has received research support from Medtronic. The institution of Dr. Ostrem has received research support from Rune.
Michael G. Benatar, MBChB, DPhil, FAAN	Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cartesian. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CorEvitas. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Canopy. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alaunos. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care.
Ima M. Ebong, MD, FAAN	The institution of Dr. Ebong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Ebong has received research support from Ad Scientiam.
Jonathan R. Galli, MD	Dr. Galli has nothing to disclose.
Tahseen Mozaffar, MD, FAAN	Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas Gene Therapy. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Astellas Gene Therpay. The institution of Dr. Mozaffar has received research support from Cartesian. The institution of Dr. Mozaffar has received research support from Cabaletta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Braedon Kirkpatrick	Braedon Kirkpatrick has nothing to disclose.
Amanda L. Piquet, MD, FAAN	The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna . The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cortez & Associates. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Falk Waas. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. The institution of Dr. Piquet has received research support from Kyverna . Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities.
Nicholas J. Silvestri, MD, FAAN	Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of an immediate family member of Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Silvestri has received publishing royalties from a publication relating to health care.
Samuel A. Frank, MD, FAAN	Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Frank has received research support from Huntington's Disease Society of America. The institution of Dr. Frank has received research support from Roche/Genentech. The institution of Dr. Frank has received research support from CHDI Foundation. The institution of Dr. Frank has received research support from Huntington Study Group. The institution of Dr. Frank has received research support from Cerevel.
David L. Perez, MD, FAAN	Dr. Perez has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley: Brain and Behavior. Dr. Perez has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Psychiatric Association Publishing. The institution of Dr. Perez has received research support from NIH. The institution of Dr. Perez has received research support from Sidney R. Baer Jr. Foundation. The institution of Dr. Perez has received research support from Warren Alpert Foundation. Dr. Perez has received publishing royalties from a publication relating to health care. Dr. Perez has received publishing royalties from a publication relating to health care.
Nargiza Chekeeva	Nargiza Chekeeva has nothing to disclose.
Kevin C. O'Connor, PhD	Kevin C. O'Connor, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Immunovant. Kevin C. O'Connor, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Kevin C. O'Connor, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurocrine. Kevin C. O'Connor, PhD has stock in Cabaletta. The institution of Kevin C. O'Connor, PhD has received research support from Seismic. The institution of Kevin C. O'Connor, PhD has received research support from Argenx. Kevin C. O'Connor, PhD has received intellectual property interests from a discovery or technology relating to health care.
Martijn Beudel, MD, PhD	Dr. Beudel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic .
Katherine E. Beard, MD	Miss Beard has nothing to disclose.
Olivia Mattner, DO	Dr. Mattner has nothing to disclose.
Yvette Bordelon, MD, PhD, FAAN	Dr. Bordelon has nothing to disclose.
Ying Li	Ying Li has received personal compensation for serving as an employee of EMD Serono.
Luisa H. Klotz, MD	Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Klotz has received research support from Immunic AG. The institution of Dr. Klotz has received research support from Merck.
Myrka R. Torres-Melendez, MD	Dr. Torres-Melendez has nothing to disclose.
Adys Mendizabal, MD, MS	Dr. Mendizabal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Clinical ��ɫ�� Alliance. Dr. Mendizabal has received research support from Huntington's Disease Society of America. Dr. Mendizabal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Huntington's Disease Society of America (HDSA).
Daniela B. Renedo, MD	Dr. Renedo has nothing to disclose.
Raman Singh, MD, MBBS	Dr. Singh has nothing to disclose.
Helen Azevedo	No disclosure on file
Bharti Manwani, MD	Dr. Manwani has nothing to disclose.
Artur Druzdz	Artur Druzdz has nothing to disclose.
Sarah Bou Reslan, MD	Dr. Bou Reslan has nothing to disclose.
Sharlet Anderson, PhD	Dr. Anderson has nothing to disclose.
Jana Podhorna	Dr. Podhorna has received personal compensation for serving as an employee of argenx. Dr. Podhorna has stock in argenx.
Saud Sadiq, BS, FAAN	Ms. Brewi has nothing to disclose.
Shane English	No disclosure on file
Friedemann Paul	Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation.
Todd Herrington, MD	Dr. Herrington has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic, Inc. Dr. Herrington has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MarvelBiome. Dr. Herrington has received personal compensation in the range of $0-$499 for serving as an Expert Witness for CRICO. The institution of Dr. Herrington has received research support from NIH/NINDS (K23NS099380).
Brittany Duncan	No disclosure on file
Narges Rahimi, MD	Dr. Rahimi has nothing to disclose.
Pushpa Narayanaswami, MD, MBBS, FAAN	Dr. Narayanaswami has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for UCB. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx USA. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD pharma. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD-Serono (Merck usa). Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Immuneabs. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viridian. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta-Bio. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Bio. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve, Wiley. Dr. Narayanaswami has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Narayanaswami has or had stock in Dr. Reddys laboratories.Dr. Narayanaswami has or had stock in Doximity. The institution of Dr. Narayanaswami has received research support from Alexion. The institution of Dr. Narayanaswami has received research support from NIH. The institution of Dr. Narayanaswami has received research support from Argenx. The institution of Dr. Narayanaswami has received research support from Cabaletta Bio. Dr. Narayanaswami has received publishing royalties from a publication relating to health care. Dr. Narayanaswami has a non-compensated relationship as a Member, Finance Committee with AANEM that is relevant to AAN interests or activities.
Alfred B. Amendolara, Jr., MD	Dr. Amendolara has nothing to disclose.
Kamleshun Ramphul	Kamleshun Ramphul has nothing to disclose.
Laura Myers	The institution of Laura Myers has received research support from VA.
Adreesh Mukherjee, MD	Dr. Mukherjee has nothing to disclose.
Elina Zakin, MD, FAAN	The institution of Dr. Zakin has received research support from American Board of Psychiatry and Neurology.
Maram S. AL Anbar, Jr., MD	Dr. AL Anbar has nothing to disclose.
Dhivyaa Rajasundaram	Dhivyaa Rajasundaram has nothing to disclose.
Afaaq Ahmed	Mr. Ahmed has nothing to disclose.
Anishee S. Undavia, MD	Dr. Undavia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Undavia has received personal compensation in the range of $0-$499 for serving as a Consultant for Inlightened.
Yingkai Li, MD, PhD	Dr. Li has nothing to disclose.
Eric Engebretson	Mr. Engebretson has nothing to disclose.
Patrick Vermersch	Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Raed Gasemaltayeb, MD	Dr. Gasemaltayeb has nothing to disclose.
Raghav Govindarajan, MD, FAAN	Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Salma Bashayreh, MD	Dr. Bashayreh has nothing to disclose.
Jeffrey Waugh, MD, PhD, FAAN	Dr. Waugh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Two independent law firms. The institution of Dr. Waugh has received research support from AAN.
Roxana M. Dragomir, MD	Dr. Dragomir has nothing to disclose.
Brianna J. Sennott, MD	An immediate family member of Dr. Sennott has received personal compensation for serving as an employee of Abbott Laboratories.
Kan Ding, MD	The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
Kelly Sloane, MD	The institution of Dr. Sloane has received research support from American Heart Association.
Dennis J. Selkoe, MD, FAAN	Dr. Selkoe has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Prothena Biosciences. Dr. Selkoe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI.
Saskia Bresch, MD	Dr. Bresch has nothing to disclose.
Maysaa M. Basha, MD, FAAN	Dr. Basha has nothing to disclose.
Cara Kizilbash	Miss Kizilbash has nothing to disclose.
Kogul Arumaithurai, MD	Dr. Arumaithurai has nothing to disclose.
Enric Monreal Laguillo	Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers Squibb.
Chindo B. Mallum, MD	Dr. Mallum has nothing to disclose.
Julio C. Furlan, MD, PhD, MBA, MSc, FAAN	The institution of Dr. Furlan has received research support from Wings for Life Spinal Cord Research Foundation. The institution of Dr. Furlan has received research support from Craig H Neilsen Foundation. The institution of Dr. Furlan has received research support from Ontario Neurotrauma Foundation. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from J P Bickell Foundation. The institution of Dr. Furlan has received research support from Praxis Spinal Cord Institute. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from CRANIA. The institution of Dr. Furlan has received research support from Craig H Neilsen Foundation. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from Tanenbaum Institute for Science in Sport. .
Holly Martin	Holly Martin has nothing to disclose.
Charlotte Thim Hansen	Charlotte Thim Hansen has received personal compensation for serving as an employee of Novo Nordisk A/S.
Guillemette De La Borderie	No disclosure on file
Marie Bentsen	Marie Bentsen has received personal compensation for serving as an employee of Novo Nordisk.
Chandler Gill, MD	Dr. Gill has nothing to disclose.
Aaron E. Izenberg, MD	Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexxion. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alnylam.
Julian Grosskreutz	Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Grosskreutz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. The institution of Dr. Grosskreutz has received research support from Boris Canessa Foundation.
Johanne M. Kaplan, PhD	Dr. Kaplan has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Kaplan has stock in ProMIS Neurosciences. Dr. Kaplan has received intellectual property interests from a discovery or technology relating to health care.
Maria Vassilaki, MD, PhD	Dr. Vassilaki has stock in Abbott Laboratories. Dr. Vassilaki has stock in Johnson and Johnson. Dr. Vassilaki has stock in Medtronic. Dr. Vassilaki has stock in Amgen. Dr. Vassilaki has stock in AbbVie. Dr. Vassilaki has stock in Merck. The institution of Dr. Vassilaki has received research support from NIH. The institution of Dr. Vassilaki has received research support from European Union/ St. Anne's University Hospital Brno, Czech Republic. The institution of an immediate family member of Dr. Vassilaki has received research support from Avobis Bio, LLC.
Sean Selva	Sean Selva has nothing to disclose.
Valeria Roldan	Dr. Roldan has nothing to disclose.
Bushra Javed, MD	Dr. Javed has nothing to disclose.
Hemani Ticku, MD	Dr. Ticku has nothing to disclose.
Latha Ganti, MD, MS, MBA, FACEP	Dr. Ganti has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ganti has received publishing royalties from a publication relating to health care.
David Walk, MD, FAAN	No disclosure on file
Brandon Giglio, MD	Dr. Giglio has nothing to disclose.
Alfonso Fasano, MD, PhD, FAAN	Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceregate. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Inbrain Neuroelectronics. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annovis. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CADTH. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society. The institution of Dr. Fasano has received research support from Boston Scientific. The institution of Dr. Fasano has received research support from Medtronic. The institution of Dr. Fasano has received research support from Abbvie. The institution of Dr. Fasano has received research support from Canadian Institutes of Health Research (CIHR). The institution of Dr. Fasano has received research support from Michael J Fox Foundation. The institution of Dr. Fasano has received research support from Bluerock Therapeutics. Dr. Fasano has received publishing royalties from a publication relating to health care. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with CenteR for Advancing Neurological Innovation to Application (CRANIA) that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with HopeNET that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Member with Tremor Research Group that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Co-Chair with Tremor Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with NPH Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with Industry Committee of the IPMDS that is relevant to AAN interests or activities.
Kelly G. Gwathmey, MD	Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Benjamin D. Tolchin, MD, MS, FAAN	The institution of Dr. Tolchin has received research support from C.G. Swebilius Trust.
Yung-Tian Gau, MD, PhD	Dr. Gau has nothing to disclose.
David C. Preston, MD, FAAN	Dr. Preston has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FBI, US Attorney, Insurance Fraud Investigative Units. Dr. Preston has received publishing royalties from a publication relating to health care.
Pooneh Memar Ardestani, MD, PhD	Dr. Memar Ardestani has nothing to disclose.
Gary W. Clauser, MD	Dr. Clauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bigoen . The institution of Dr. Clauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Clauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech . Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genzyme. Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Novartid.
Michael T. Pulley, MD, PhD, FAAN	Dr. Pulley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amylyx. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for csl/behring. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta. Dr. Pulley has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Multiple law firms.
Rodrigo Zepeda, MD	The institution of Dr. Zepeda has received research support from NIH.
Alvee Saluja, DM	Dr. Saluja has nothing to disclose.
Roger E. Kelley, Jr., MD, FAAN	Dr. Kelley has nothing to disclose.
Santiago Clocchiatti-Tuozzo	Mr. Clocchiatti-Tuozzo has nothing to disclose.
Jonathan B. Thomas, MBA	Mr. Thomas has nothing to disclose.
Hong Sun, MD, PhD	Dr. Sun has received personal compensation for serving as an employee of Janssen.
Nabeel Ahmed	Mr. Ahmed has nothing to disclose.
Mustafa Jaffry	Mr. Jaffry has nothing to disclose.
Kimiaki Utsugisawa, MD, PhD	Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Utsugisawa has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubisi Tanabe pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for argenx. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion phama. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Japan Blood Products Organization. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
Joachim Scholz, MD	Dr. Scholz has received personal compensation for serving as an employee of Alexion AstraZeneca Rare Disease. Dr. Scholz has stock in Alexion AstraZeneca Rare Disease. Dr. Scholz has stock in Biogen. Dr. Scholz has received intellectual property interests from a discovery or technology relating to health care.
Andrew Stern, MD	Dr. Stern has nothing to disclose.
Fernando Cendes, MD, PhD, FAAN	Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Wei Yin	Wei Yin has received personal compensation for serving as an employee of Takeda. Wei Yin has stock in Takeda.
Kelly Harper	Ms. Harper has nothing to disclose.
Sam Payabvash	Sam Payabvash has nothing to disclose.
Leticia F. Ribeiro	Ms. Ribeiro has nothing to disclose.
Matthew J. Rosene, PhD	Dr. Rosene has nothing to disclose.
Jin-Hong Shin	No disclosure on file
Brandy Fureman, PhD	Dr. Fureman has received personal compensation for serving as an employee of Epilepsy Foundation. Dr. Fureman has or had stock in EnlitenAI. The institution of Dr. Fureman has received research support from Jazz Pharmaceuticals, Inc. The institution of Dr. Fureman has received research support from NINDS/NIH. The institution of Dr. Fureman has received research support from CDC. Dr. Fureman has a non-compensated relationship as a Owner with Neuroscience Navigators, LLC that is relevant to AAN interests or activities.
Babak Boroojerdi, MD	Dr. Boroojerdi has received personal compensation for serving as an employee of UCB Biosciences. Dr. Boroojerdi has stock in UCB Biosciences.
Joel Neves Briard, MD	Dr. Neves Briard has received research support from ��ɫ��.
Erin Furr-Stimming, MD, FAAN	Dr. Furr-Stimming has received personal compensation for serving as an employee of Help4HD International. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedPage. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Latus Bio. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atalanta Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SkyHawk Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atalanta Therapeutics. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine Bioscienes. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from Sage Therapeutics. The institution of Dr. Furr-Stimming has received research support from HDSA. The institution of Dr. Furr-Stimming has received research support from Prilennia. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has a non-compensated relationship as a Committee member with AAN UES Committee that is relevant to AAN interests or activities.
Clifford R. Jack, Jr., MD	The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
John W. Lindsey, MD	Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Banner Life Sciences. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mapi. Dr. Lindsey has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Teva. The institution of Dr. Lindsey has received research support from Genentech.
Katheryn Woo	No disclosure on file
Poojith Nuthalapati, MD	Mr. Nuthalapati has nothing to disclose.
John Vissing, MD	Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Prof. Vissing has received personal compensation in the range of $0-$499 for serving as a Consultant for Denali Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Italfarmaco. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Prof. Vissing has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson (Janssen). Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Edgewise Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Prof. Vissing has received research support from Rigshospitalet. The institution of Prof. Vissing has received research support from Avidity. The institution of Prof. Vissing has received research support from Sanofi. The institution of Prof. Vissing has received research support from Roche. The institution of Prof. Vissing has received research support from AnnJi.
Yuebing Li, MD, PhD, FAAN	Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex. The institution of Dr. Li has received research support from Argenx.
Serena Simpson, MD	Ms. Simpson has nothing to disclose.
Wendemi Sawadogo	Dr. Sawadogo has nothing to disclose.
Negar Moheb, MD	Dr. Moheb has nothing to disclose.
Hea Ree Park	Hea Ree Park has nothing to disclose.
Ann Liebert, PhD	Dr. Liebert has received personal compensation for serving as an employee of Symbyx Pty Ltd. Dr. Liebert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SymByx Pty Ltd. Dr. Liebert has stock in SymByx Pty Ltd. The institution of Dr. Liebert has received research support from Gardos family Trust.
Jeff Guptill, MD, FAAN	Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has or had stock in argenx.
Michael D. Weiss, MD, FAAN	Dr. Weiss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB-RA. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Soleo. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Elizabeth Crabtree-Hartman, MD	Dr. Crabtree-Hartman has nothing to disclose.
Kanika Sharma	Ms. Sharma has nothing to disclose.
Mary Jo Pugh, PhD, RN, FAAN	The institution of Dr. Pugh has received research support from Department of Defense, Epilepsy Research Program. The institution of Dr. Pugh has received research support from VA Health Services Research and Development Service. The institution of Dr. Pugh has received research support from VA Rehabilitation Research and Development Service. The institution of Dr. Pugh has received research support from Congressionally Directed Research Programs.
Ahmed M. Yassin, MD	Dr. Yassin has nothing to disclose.
Petra W. Duda, MD, PhD	Dr. Duda has received personal compensation for serving as an employee of UCB. Dr. Duda has stock in UCB.
Octavio Carranza-Renteria, MD	Dr. Carranza-Renteria has nothing to disclose.
Khawla M. Abusamra, MBBS	Dr. Abusamra has nothing to disclose.
Zufe Rizvi, MD	Dr. Rizvi has nothing to disclose.
Jeremy Moeller, MD, FAAN	Dr. Moeller has received publishing royalties from a publication relating to health care.
Adam De Havenon, MD, FAAN	Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Neelam Goyal, MD, FAAN	Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Goyal has received research support from Argenx.
Ericka P. Greene, MD, FAAN	Dr. Greene has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis . Dr. Greene has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Abraham & Watkins Texas Law Firm. The institution of Dr. Greene has received research support from National Science Foundaton .
Richard J. Nowak, MD	Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janseen . The institution of Dr. Nowak has received research support from UCB. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Janseen. The institution of Dr. Nowak has received research support from Immunovant . The institution of Dr. Nowak has received research support from argenx. The institution of Dr. Nowak has received research support from Amgen. Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to AAN interests or activities.
Cyprien Rivier, MD	Dr. Rivier has nothing to disclose.
Jeffrey R. Buchhalter, MD, FAAN	Dr. Buchhalter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Foundation. Dr. Buchhalter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epilepsy Study Consortium. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex. Dr. Buchhalter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona.
Alexander Buslov, MD	Dr. Buslov has nothing to disclose.
Susan L. Perlman, MD	Dr. Perlman has nothing to disclose.
Zara A. Togher, MB BCh BAO	Dr. Togher has nothing to disclose.
Rebecca MacRae, MD	Dr. MacRae has nothing to disclose.
Alanna McEneny	Alanna McEneny has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Alanna McEneny has stock in AstraZeneca.
Thomas Gill	Thomas Gill has nothing to disclose.
Jeremiah Aakre, MPH	Mr. Aakre has nothing to disclose.
Brendan J. Kelley, MD, FAAN	Dr. Kelley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Labcorp. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai.
Sanjeeva R. Onteddu, MD, FAAN	Dr. Onteddu has nothing to disclose.
Denis Korobko	Denis Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Denis Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Denis Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Denis Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biocad. Denis Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Denis Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Denis Korobko has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for sanofi. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jhonson&Jhonson. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra-Zeneca. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Russia. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Moscow. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra-Zeneca. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biocad. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Generium. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Sarah Harris	Sarah Harris has received personal compensation for serving as an employee of BMS. Sarah Harris has stock in BMS.
Hamza M. Ahmed, MBBS	Dr. Ahmed has nothing to disclose.
Shitiz K. Sriwastava, MBBS	Dr. Sriwastava has nothing to disclose.
Gulin Sunter	No disclosure on file
Qiang J. Zhang, MD	The institution of Dr. Zhang has received research support from NIH/NIA.
Aparna M. Prabhu, MD	Dr. Prabhu has nothing to disclose.
Claire McGee, PT	Ms. McGee has nothing to disclose.
P. D. Charles, MD, FAAN	Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iota. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceraxis. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspen Neuroscience. Dr. Charles has stock in Arena Therapeutics. The institution of Dr. Charles has received research support from Pharma 2 B. The institution of Dr. Charles has received research support from Intec. The institution of Dr. Charles has received research support from Merz. The institution of Dr. Charles has received research support from Novartis. The institution of Dr. Charles has received research support from Aeon. The institution of Dr. Charles has received research support from Impax. The institution of Dr. Charles has received research support from AskBio. The institution of Dr. Charles has received research support from BlueRock. The institution of Dr. Charles has received research support from AbbVie. The institution of Dr. Charles has received research support from Ipsen.
Mark Agostini, MD	Dr. Agostini has nothing to disclose.
Georgiana Kuhlmann	Georgiana Kuhlmann has stock in Amgen.
Eun-Yeon Joo, MD	Dr. Joo has nothing to disclose.
Travis J. Hassell, MD, PhD	No disclosure on file
Masayuki Masuda	Masayuki Masuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alexion pharma, Argenix pharma, Aasahi kasei pharma, UCB, Takeda pharma.
Clarissa L. Yasuda, MD, PhD	Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Renato Mantegazza, MD	Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Mantegazza has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SERB. The institution of Dr. Mantegazza has received research support from Alpine Immune Sciences, Inc.
Min Yee	Min Yee has nothing to disclose.
Agessandro Abrahao, Jr., MD	Dr. Abrahao has nothing to disclose.
Alan R. Hirsch, MD, FACP	Dr. Hirsch has nothing to disclose.
Christopher Adams, MD	Dr. Adams has stock in Medtronic.
Deepti Zutshi, MD, FAAN	Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
Farnaz Khalighinejad, MD	Dr. Khalighinejad has nothing to disclose.
Maria Luisa Martinez Gines, MD	Dr. Martinez Gines has nothing to disclose.
Rebecca T. Hsu, MD	Dr. Hsu has nothing to disclose.
Franz Woltering	No disclosure on file
Enrique Alvarez, MD, PhD	Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Daniel R. Weinberger, MD	No disclosure on file
Rebekah L. Summers, PhD, PT	Rebekah Summers has received personal compensation for serving as an employee of Medtronic. Rebekah Summers has received research support from National Institute of Health.
Francesco Sacca, MD, FAAN	Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lexeo. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genpharm. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medpharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Madison Pharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zai Lab. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neopharm Israel. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson&Johnson. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Sacca has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Astrazeneca. The institution of Dr. Sacca has received research support from AIFA. The institution of Dr. Sacca has received research support from FARA.
Sarah Ingersoll, RN, PHN	Ms. Ingersoll has nothing to disclose.
Thapat Wannarong, MD	Dr. Wannarong has nothing to disclose.
Ludwig Kappos, MD, FAAN	Dr. Kappos has nothing to disclose.
Adrian Rodriguez-Hernandez, MD	Dr. Rodriguez-Hernandez has nothing to disclose.
Alexandra Durr, MD	The institution of Dr. Durr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Durr has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. The institution of Dr. Durr has received research support from NIH. The institution of Dr. Durr has received research support from BIOGEN. The institution of Dr. Durr has received research support from MINORYX. The institution of Dr. Durr has received research support from TRIPLETS THERAPEUTICS. The institution of Dr. Durr has received research support from Servier. The institution of Dr. Durr has received research support from ANR. The institution of Dr. Durr has received research support from PTC.
Raj Bandaru	Mr. Bandaru has received personal compensation for serving as an employee of Alexion Pharmaceuticals.
Brigitte Wildemann, MD	The institution of Dr. Wildemann has received research support from Roche. The institution of Dr. Wildemann has received research support from Novartis. The institution of Dr. Wildemann has received research support from Argenx. Dr. Wildemann has received personal compensation in the range of $500-$4,999 for serving as a Conference participant with Neuraxpharm. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Speaker with Roche. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Soeaker with Instand.
Adrian Newland	No disclosure on file
Kenneth Hayashida	Kenneth Hayashida has nothing to disclose.
Goutam Gangopadhyay	No disclosure on file
Lisa Tonder	Lisa Tonder has received personal compensation for serving as an employee of Medtronic. An immediate family member of Lisa Tonder has received personal compensation for serving as an employee of Medtronic.
Jordan Broman-Fulks, MD	No disclosure on file
Rohit Das, MD, FAAN	Dr. Das has received personal compensation for serving as an employee of Oregon Health Science University. Dr. Das has received personal compensation in the range of $10,000-$49,999 for serving as a Physician Advisor with Concentra .
Yuzhou Guan	No disclosure on file
Minh C. Pham	Mr. Pham has nothing to disclose.
Yaseen Yacoob, MD	Dr. Yacoob has nothing to disclose.
Helen Bronte-Stewart, MD, MSE	Dr. Bronte-Stewart has stock in QDG Health. Dr. Bronte-Stewart has received intellectual property interests from a discovery or technology relating to health care.
Ruchira M. Jha, MD	Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. An immediate family member of Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal fees. The institution of Dr. Jha has received research support from NIH/NINDS, Chuck Noll Foundation, University of Pittsburgh, Barrow Neurological Foundation.
Armin Maghsoudlou, MD	Dr. Maghsoudlou has nothing to disclose.
Animesh Das, MD	Dr. Das has nothing to disclose.
Heinz Wiendl, MD, FAAN	Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Maria Donahue	Maria Donahue has nothing to disclose.
Sindhu Ramchandren, MD	Dr. Ramchandren has received personal compensation for serving as an employee of Janssen Pharmaceutical Companies of Johnson & Johnson.
Geoffrey K. Herkes, MBBS, PhD, FRACP	The institution of Dr. Herkes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Epiminder. Dr. Herkes has received personal compensation in the range of $5,000-$9,999 for serving as a Chair of Advisory Committee of Medicines with Therapeutic Goods Admin.
James F. Howard, Jr., MD, FAAN	Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx . Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN (Horizon Therapeutics). Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Ltd. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck EMD Serono. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for H. Lundbeck A/S. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Seismic Therapeutics. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Biopharma. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Academic CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PeerView CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Platform Q CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for MJH LifeSci. Dr. Howard has or had stock in Johnson & Johnson dividends.Dr. Howard has or had stock in Pfizer dividends. An immediate family member of Dr. Howard has or had stock in GlaxoSmithKline dividends.Dr. Howard has or had stock in Bristol Myer Squbb dividends.Dr. Howard has or had stock in AbbieVie Inc. The institution of Dr. Howard has received research support from Alexion Pharmaceuticals. The institution of Dr. Howard has received research support from argenx . The institution of Dr. Howard has received research support from UCB Biosciences. The institution of Dr. Howard has received research support from NIH. The institution of Dr. Howard has received research support from Centers for Disease Control/Research Triangle Institute. The institution of Dr. Howard has received research support from Cartestian Therapeutics. The institution of Dr. Howard has received research support from NMD Pharma. The institution of Dr. Howard has received research support from Ad Scientiam. The institution of Dr. Howard has received research support from Merck EMD Serono. Dr. Howard has a non-compensated relationship as a Scientific Advisiory Board member, Committee member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Howard has a non-compensated relationship as a Committee member with American Assoc Neuromuscular and Electrodiagnostic Medicine that is relevant to AAN interests or activities.
Henry M. Lee III, MD	Dr. Lee has nothing to disclose.
Joao Vitor Mahler, MD	Dr. Mahler has received research support from The Sumaira Foundation.
Jenna Casey	Jenna Casey has received personal compensation for serving as an employee of argenx.
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Juan Pablo Cuello	Juan Pablo Cuello has nothing to disclose.
Elif P. Coskun, MD	Dr. Coskun has nothing to disclose.
Andreas Meisel	Andreas Meisel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Andreas Meisel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Adivo. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Andreas Meisel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. The institution of Andreas Meisel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Andreas Meisel has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Andreas Meisel has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for argenx. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer/BMS. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Axunio. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Desitin. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genpharm. The institution of Andreas Meisel has received research support from Alexion. The institution of Andreas Meisel has received research support from argenx. The institution of Andreas Meisel has received research support from Octapharma. The institution of Andreas Meisel has received research support from Deutsche Myasthenie Gesellschaft. The institution of Andreas Meisel has received research support from Deutsche Forschungsgemeinschaft . The institution of Andreas Meisel has received research support from Bundesministerium für Wissenschaft und Forschung. The institution of Andreas Meisel has received research support from Leducq Foundation. The institution of Andreas Meisel has received research support from Einstein Stiftung Berlin. Andreas Meisel has received publishing royalties from a publication relating to health care. Andreas Meisel has received publishing royalties from a publication relating to health care. Andreas Meisel has a non-compensated relationship as a Chairman, Medical Advisory Board with Deutsche Myasthenie Gesellschaft that is relevant to AAN interests or activities. Andreas Meisel has a non-compensated relationship as a Chairman with Berliner Schlaganfall Gesellschaft that is relevant to AAN interests or activities.
Shazia Mirza, MBBS	Dr. Mirza has nothing to disclose.
Brian Sacks, DO	Dr. Sacks has nothing to disclose.
Marisara Dieppa, MD	Dr. Dieppa has nothing to disclose.
Stefan Bittner	Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Biogen Idec. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Merck Healthcare. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Novartis. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Roche. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Sanofi. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Bristol-Meyer-Squibbs. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Teva.
Courtney Seigel, MD	Miss Seigel has nothing to disclose.
Violaine K. Harris, PhD	No disclosure on file
Yu-Ting Chen, MD	Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam.
Mya C. Schiess, MD, FAAN	Dr. Schiess has nothing to disclose.
Eonjung Kim, MD	Dr. Kim has nothing to disclose.
Maithreyi Chappidi, MD	Dr. Chappidi has nothing to disclose.
Vanessa Sui, MD	Dr. Sui has nothing to disclose.
Thiago D. Pinheiro, MD	Dr. Pinheiro has nothing to disclose.
Kadriye Agan	Kadriye Agan has nothing to disclose.
Rene Kerstens	No disclosure on file
Henry J. Kaminski, MD, FAAN	Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta Bio. The institution of Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canopy Immunotherapeutics. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curie.bio. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Care Constitution. Dr. Kaminski has stock in mimivax. The institution of Dr. Kaminski has received research support from National Institutes of Health. Dr. Kaminski has received publishing royalties from a publication relating to health care.
Scott Grossman, MD	Dr. Grossman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acuta Pharmaceuticals.
Aline Herlopian, MD	Dr. Herlopian has nothing to disclose.
Tobias Ruck	No disclosure on file
Anam K. Shaikh	Miss Shaikh has nothing to disclose.
Hubert H. Fernandez, MD, FAAN	Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Kelly Y. Chun, PhD	Dr. Chun has nothing to disclose.
Tandees Najimi	Ms. Najimi has received research support from National Institutes of Health's Intramural Research Program.
Elizabeth W. Fletman, DO	Dr. Fletman has nothing to disclose.
Jesse Thon, MD	An immediate family member of Dr. Thon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech.
Christopher G. Favilla, MD	The institution of Dr. Favilla has received research support from National Institutes of Health. The institution of Dr. Favilla has received research support from American Heart Association. The institution of Dr. Favilla has received research support from OpenWater, Inc..
Sergio Baranzini	Sergio Baranzini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Sergio Baranzini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono . Sergio Baranzini has stock in MATE Bioservices. The institution of Sergio Baranzini has received research support from Valhalla Charitable Fund. The institution of Sergio Baranzini has received research support from Salah Foundation. The institution of Sergio Baranzini has received research support from NIH. The institution of Sergio Baranzini has received research support from NSF. Sergio Baranzini has received intellectual property interests from a discovery or technology relating to health care. Sergio Baranzini has a non-compensated relationship as a co-funder with Mate Bioservices that is relevant to AAN interests or activities.
Beibei Zhao	Beibei Zhao has received intellectual property interests from a discovery or technology relating to health care.
Hongying Chen, MB BCh BAO	Dr. Chen has nothing to disclose.
Hester Visser	Hester Visser has received personal compensation for serving as an employee of Amneal Pharmaceuticals LLC. Hester Visser has received stock or an ownership interest from Amneal Pharmaceuticals LLC.
Sven G. Meuth	Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Shailee S. Shah, MD	Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Shah has received publishing royalties from a publication relating to health care.
Marek Smilowski	Marek Smilowski has nothing to disclose.
Tabitha Karatz	No disclosure on file
Nagaraja Sarangmat	Nagaraja Sarangmat has nothing to disclose.
Jens Kuhle, MD	Dr. Kuhle has nothing to disclose.
Angelina H. Maniaol, MD	Dr. Maniaol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Maniaol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Maniaol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Maniaol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Maniaol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Maniaol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Maniaol has received research support from ALS patient organization Alltid litt sterkere. The institution of Dr. Maniaol has received research support from Helse Sør-Øst RHF . The institution of Dr. Maniaol has received research support from Argenx. The institution of Dr. Maniaol has received research support from ALS patient organization Stiftelsen ALS Norge.
Emily Tharp, MD	Dr. Tharp has nothing to disclose.
Jan Lünemann, MD	Dr. Lünemann has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ArgenX. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma GmbH. The institution of Dr. Lünemann has received research support from German Research Foundation. The institution of Dr. Lünemann has received research support from French National Research Agency (ANR). The institution of Dr. Lünemann has received research support from National Multiple Sclerosis Society (NMSS). The institution of Dr. Lünemann has received research support from National Institute of Health.
Camila Pupe, MD	Dr. Pupe has nothing to disclose.
Anju Parthan	Anju Parthan has received personal compensation for serving as an employee of Alexion. Anju Parthan has received personal compensation for serving as an employee of Alkermes. Anju Parthan has received stock or an ownership interest from Alexion.
Hiroyuki Murai, MD	Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chugai Pharmaceutical. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Murai has received research support from Japan Blood Products Organization.
Arnav Mahajan	Mr. Mahajan has nothing to disclose.
Ashley Bailey, MD	Dr. Bailey has nothing to disclose.
Zsuzsanna Bata-Csorgo	No disclosure on file
Stanley Taylor	Stanley Taylor has nothing to disclose.
Rachel Kenney	Rachel Kenney has received personal compensation for serving as an employee of Optum. Rachel Kenney has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Minton ��ɫ�� LLC.
Bernhard Greve, MD	Dr. Greve has received personal compensation for serving as an employee of UCB Biosciences. Dr. Greve has stock in UCB Biosciences.
Vanessa K. Hinson, MD, PhD, FAAN	The institution of Dr. Hinson has received research support from Biogen. The institution of Dr. Hinson has received research support from Scion Neurostim. The institution of Dr. Hinson has received research support from PPD Development/Takeda Development. The institution of Dr. Hinson has received research support from Parexel Biopharma. The institution of Dr. Hinson has received research support from Impax Laboratories.
Haneen F. Al Refa'i	Ms. Al Refa'i has nothing to disclose.
Cankatika Choudhury, DM	Dr. Choudhury has nothing to disclose.
Jayne R. Wilkinson, MD, MSCE	Dr. Wilkinson has nothing to disclose.
Alanna Ritchie	Alanna Ritchie has nothing to disclose.
Salim Chahin, MD	Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutic . The institution of Dr. Chahin has received research support from National MS Society. The institution of Dr. Chahin has received research support from BMS.
James M. Winkley, MD	Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Sanofi. Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Teva. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. The institution of Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for J&J. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amgen . Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG therapeutics. An immediate family member of Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Teva. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Alexion. Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for BMS. Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for amgen . Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB . Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for J&J. Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for TG therapeutics. The institution of Dr. Winkley has received research support from Noveratis. The institution of Dr. Winkley has received research support from Merck. The institution of Dr. Winkley has received research support from Sanofi. The institution of Dr. Winkley has received research support from Biogen. The institution of Dr. Winkley has received research support from Alexion.
Krista Ocier, PhD	Dr. Ocier has nothing to disclose.
Christopher Melinosky, MD	Dr. Melinosky has nothing to disclose.
Khalid El-Salim	No disclosure on file
Suradech Suthiphosuwan	No disclosure on file
Khurram Bashir, MD	The institution of Dr. Bashir has received research support from NIH. The institution of Dr. Bashir has received research support from PICORI. The institution of Dr. Bashir has received research support from Sanofi. Dr. Bashir has received research support from GWSP. The institution of Dr. Bashir has received research support from Roche. The institution of Dr. Bashir has received research support from Novartis. The institution of Dr. Bashir has received research support from Hoffmann-La Roche.
Keshav J. Shah, MBBS	Mr. Shah has nothing to disclose.
Dana Allison	Ms. Allison has nothing to disclose.
Elena Ratti, MD	Dr. Ratti has received personal compensation for serving as an employee of Takeda. Dr. Ratti has received personal compensation for serving as an employee of Biogen. Dr. Ratti has stock in Takeda. Dr. Ratti has stock in Biogen.
Mohammad Shahnawaz, PhD	The institution of Dr. Shahnawaz has received research support from American Parkinson Disease Association. The institution of Dr. Shahnawaz has received research support from NIH. The institution of Dr. Shahnawaz has received research support from Texas Alzheimer's Research & Care Consortium . Dr. Shahnawaz has received intellectual property interests from a discovery or technology relating to health care.
Daniel Basoff, PharmD, RPh	Dr. Basoff has received personal compensation for serving as an employee of Alexion Pharmaceuticals.
Masahisa Katsuno	Masahisa Katsuno has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chugai. Masahisa Katsuno has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Masahisa Katsuno has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sumitomo Pharma. Masahisa Katsuno has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Masahisa Katsuno has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Viatris. The institution of Masahisa Katsuno has received research support from Sumitomo Pharma. The institution of Masahisa Katsuno has received research support from Nihon Mediphysics.
Gregory Owens, PhD	Dr. Owens has received intellectual property interests from a discovery or technology relating to health care.
Channa A. Hewamadduma, MBBS, PhD, FRCP, MSc	Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ARENX. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. The institution of Dr. Hewamadduma has received research support from Neurocare . The institution of Dr. Hewamadduma has received research support from Sheffield Charitable Trust. Dr. Hewamadduma has received personal compensation in the range of $5,000-$9,999 for serving as a Adult Expert with National Health Service England (NHSE).
Maryam H. Hosseini, MD	Dr. Hosseini has nothing to disclose.
Ventaka Bendi, MBBS	Dr. Bendi has nothing to disclose.
Zurisadai Gonzalez, MD	Dr. Gonzalez Castillo has nothing to disclose.
Glen Frick, MD, PhD	Dr. Frick has received personal compensation for serving as an employee of AstraZeneca/Alexion Rare Disease. Dr. Frick has stock in AstraZeneca/Alexion Rare Disease.
Jose Manuel Garcia Dominguez	Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Almirall. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
Sam Leo, PharmD	Dr. Leo has received personal compensation for serving as an employee of Teva Pharmaceutical Industries.
Harry Sutherland, MD	Dr. Sutherland has received publishing royalties from a publication relating to health care.
Oscar A. Vargas Cifuentes	Mr. Vargas Cifuentes has nothing to disclose.
Patrick M. Kochanek, MD, MCCM	Patrick M. Kochanek, MD, MCCM has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Washington. Patrick M. Kochanek, MD, MCCM has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Johns Hopkins Health System. Patrick M. Kochanek, MD, MCCM has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for de Boisblanc Law Firm. The institution of Patrick M. Kochanek, MD, MCCM has received research support from Chuck Noll Foundation. The institution of Patrick M. Kochanek, MD, MCCM has received research support from NIH. Patrick M. Kochanek, MD, MCCM has received publishing royalties from a publication relating to health care.
Richard D'Souza	No disclosure on file
Sarah R. Durica, MD	An immediate family member of Dr. Durica has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Federal Aviation Administration.
Maggie Moran, MD	Dr. Moran has nothing to disclose.
Ying Tan, MD	Dr. Tan has nothing to disclose.
Frauke Zipp, MD	Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Zipp has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. The institution of Dr. Zipp has received research support from BMBF. The institution of Dr. Zipp has received research support from DFG. The institution of Dr. Zipp has received research support from PMSA. The institution of Dr. Zipp has received research support from Sanofi Genzyme. The institution of Dr. Zipp has received research support from UCB. The institution of Dr. Zipp has received research support from Eisai. The institution of Dr. Zipp has received research support from SK Life Science. The institution of Dr. Zipp has received research support from Abbott. The institution of Dr. Zipp has received research support from Actelion. The institution of Dr. Zipp has received research support from Bayer. The institution of Dr. Zipp has received research support from Servier. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with Novartis. Dr. Zipp has received personal compensation in the range of $0-$499 for serving as a Reviewer with Universite de Geneve. Dr. Zipp has received personal compensation in the range of $5,000-$9,999 for serving as a Reviewer with Oppenheim Förderpreis für Multiple Sklerose. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with EKFS. Dr. Zipp has a non-compensated relationship as a Associate Editor with Brain that is relevant to AAN interests or activities. Dr. Zipp has a non-compensated relationship as a Advisor with Science Translational Medicine that is relevant to AAN interests or activities.
Michael F. Cronin	The institution of Mr. Cronin has received research support from American Heart Association.
Alexander Sherman	The institution of Mr. Sherman has received research support from The ALS Association. The institution of Mr. Sherman has received research support from NIH. The institution of Mr. Sherman has received research support from FDA. The institution of Mr. Sherman has received research support from Biogen. The institution of Mr. Sherman has received research support from Amylyx Pharmaceuticals. The institution of Mr. Sherman has received research support from Mitsubishi-Tanabe Pharma America. Mr. Sherman has a non-compensated relationship as a Member, Board of Directors with ALD Connect that is relevant to AAN interests or activities.
Joseph M. Palumbo, MD	Dr. Palumbo has received personal compensation for serving as an employee of BioVie. An immediate family member of Dr. Palumbo has received personal compensation for serving as an employee of Merck Research Laboratories. Dr. Palumbo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stalicla SA. Dr. Palumbo has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Psychae Therapeutics Pty Ltd. Dr. Palumbo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Phocus Pharmaceuticals Inc.. Dr. Palumbo has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for BioVie. Dr. Palumbo has or had stock in BioVie. An immediate family member of Dr. Palumbo has or had stock in Merck Research Laboratories. The institution of Dr. Palumbo has received research support from United States Department of Defense. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care.
Hamada H. Altalib, DO	The institution of Dr. Altalib has received research support from UCB. The institution of Dr. Altalib has received research support from DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS.
Thomas C. Hammond, MD, FAAN	Dr. Hammond has nothing to disclose.
Yasushi Suzuki, MD, PhD	Yasushi Suzuki, MD, PhD has nothing to disclose.
Andrew Morrison, MD	Dr. Morrison has nothing to disclose.
Jennifer H. Newman, MD	Dr. Newman has nothing to disclose.
Luis A. Sierra, Jr.	Mr. Sierra has nothing to disclose.
Muhammad Makkieh, DO	Dr. Makkieh has nothing to disclose.
Emma McFadden, PhD	Dr. McFadden has nothing to disclose.
Eunice J. Lee, MD	Dr. Lee has nothing to disclose.
Alex Berger, BS	Mr. Berger has nothing to disclose.
Bhaswar Bhattacharya, Jr.	Dr. Bhattacharya has nothing to disclose.
Kranthi K. Mandava	Mr. Mandava has nothing to disclose.
Shayan A. Zadegan, MD	Dr. Zadegan has nothing to disclose.
Neil Cashman, MD	Dr. Cashman has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Cashman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IONIS. Dr. Cashman has stock in ProMIS Neurosciences. The institution of Dr. Cashman has received research support from ProMIS Neurosciences. Dr. Cashman has received intellectual property interests from a discovery or technology relating to health care.
Pradeepthi Badugu, MBBS	Dr. Badugu has nothing to disclose.
Nouf S. Al-Faidi, MD	Dr. Al-Faidi has nothing to disclose.
Will K. Tanigaki, MD	Mr. Tanigaki has nothing to disclose.
Ming Jiang	No disclosure on file
Matteo Locatelli, BS	Mr. Locatelli has nothing to disclose.
Jori Fleisher, MD, MSCE, FAAN	The institution of Dr. Fleisher has received research support from Parkinson's Foundation. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. Dr. Fleisher has received publishing royalties from a publication relating to health care. Dr. Fleisher has received personal compensation in the range of $0-$499 for serving as a Speaker with Parkinson's Foundation. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lewy Body Dementia Association. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Davis Phinney Foundation. Dr. Fleisher has a non-compensated relationship as a Editorial Board Member with AAN Brain & Life Magazine that is relevant to AAN interests or activities.
Ahmer Asif, MD	Dr. Asif has nothing to disclose.
Karen Truitt, DO	Dr. Truitt has stock in QTRX. Dr. Truitt has stock in EXAS. Dr. Truitt has stock in ACAD. Dr. Truitt has stock in ABBV. Dr. Truitt has stock in NVS. Dr. Truitt has stock in VRTX. Dr. Truitt has stock in MRK.
Sathvik S. Shastry, MD	Dr. Shastry has nothing to disclose.
Rory Abrams, MD	Dr. Abrams has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Averitas Pharmaceutical.
Maryam Gayfieva	No disclosure on file
James K. Sheffield, MD	Dr. Sheffield has received personal compensation for serving as an employee of BMS.
Ebrima Gibbs, Bsc, BMLSc, MSc	Dr. Gibbs has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Promis Neurosciences.
Ahmad Al-Awwad, MD	Dr. Al-Awwad has nothing to disclose.
Maria D. Olaya Galindo, MD	Mrs. Olaya Galindo has nothing to disclose.
Audrey S. Wack, MD	The institution of an immediate family member of Miss Wack has received research support from Canon Medical Systems USA, Inc.
Leonardo Almeida	No disclosure on file
Kathleen Beasley, PharmD	Dr. Beasley has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Dr. Beasley has received stock or an ownership interest from Alexion, AstraZeneca Rare Disease.
Denise K. Sebasigari, MD	Dr. Sebasigari has nothing to disclose.
Lucy Gee, PhD	Dr. Gee has nothing to disclose.
Rohini D. Samudralwar, MD	Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Nicole Sukkarieh, MD	Ms. Sukkarieh has nothing to disclose.
Vera Bril, MD	Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Hisham G. Elkhider, MD	Dr. Elkhider has nothing to disclose.
Hans D. Katzberg, MD, FAAN	An immediate family member of Dr. Katzberg has received personal compensation for serving as an employee of Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Katzberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX.
Ghazala Perven, MD	Dr. Perven has nothing to disclose.
Natalia Pessoa Rocha	Natalia Pessoa Rocha has nothing to disclose.
Thirumalaivasan Dhasakeerthi, MBBS	Dr. Dhasakeerthi has nothing to disclose.
Jessica Sanders, MD	The institution of Dr. Sanders has received research support from Child Neurology Foundation. The institution of Dr. Sanders has received research support from NIH. The institution of Dr. Sanders has received research support from HRSA.
Denis Babici, MD	Dr. Babici has nothing to disclose.
Christopher B. Traner, MD	Dr. Traner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuropace. Dr. Traner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell Inc. Dr. Traner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Resident Matching Program .
Sara A. Alnajjar, Jr., MD	Dr. Alnajjar has nothing to disclose.
Svetlana Faktorovich, MD, FAAN	Dr. Faktorovich has a non-compensated relationship as a member of the Board of Trustees with Brother's Brother Foundation that is relevant to AAN interests or activities.
Dennis W. Simon, MD	Dr. Simon has nothing to disclose.
Juergen Haas	Juergen Haas has nothing to disclose.
Seneca Oxendine	Ms. Oxendine has nothing to disclose.
Mark F. Gordon, MD, FAAN	Dr. Gordon has received personal compensation for serving as an employee of Teva. Dr. Gordon has stock in Teva.
Divya M. Radhakrishnan, MD, DM (Neurology)	The institution of Dr. Radhakrishnan has received research support from Indian Council of Medical Research, New Delhi, India. Dr. Radhakrishnan has received research support from International Parkinson's and Movement Disorders Society, Asian Oceanian Section .
Yash Nene, MBBS	Dr. Nene has nothing to disclose.
Charlene J. Ong, MD	Dr. Ong has nothing to disclose.
Nicholas Schwab	The institution of Nicholas Schwab has received research support from Biogen. The institution of Nicholas Schwab has received research support from Roche.
Eric Molho, MD, FAAN	Dr. Molho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Molho has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CNS Ratings. Dr. Molho has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences.
Elena Moro, MD, FAAN	Dr. Moro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Moro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Moro has received research support from Abbott. The institution of Dr. Moro has received research support from Medtronic.
Laura Fumagalli	No disclosure on file
Mohsen Ahmed	Mr. Ahmed has nothing to disclose.
Padmaja Sudhakar, MD	Dr. Sudhakar has nothing to disclose.
Marion Boehnlein	Marion Boehnlein has stock in UCB.
Ramsha A. Bhutta, MD	Dr. Bhutta has nothing to disclose.
Tyler L. Borko, BA	Mr. Borko has nothing to disclose.
Kaitlyn Lillemoe, MD	Dr. Lillemoe has nothing to disclose.
Julia S. Frueh, MD	Dr. Frueh has received research support from ACGME Back to Bedside.
Joshua Chodosh, MD	The institution of Dr. Chodosh has received research support from NIH-NIA. The institution of Dr. Chodosh has received research support from NIH-NINR.
Malissa Pynes, MD	Dr. Pynes has nothing to disclose.
Christa S. Cooper, PA	No disclosure on file
Brooke Valdez	Brooke Valdez has nothing to disclose.
Christopher Hemond, MD	The institution of Dr. Hemond has received research support from Consorium of Multiple Sclerosis Centers. The institution of Dr. Hemond has received research support from National Institute Of Neurological Disorders And Stroke of the National Institutes of Health. Dr. Hemond has received personal compensation in the range of $0-$499 for serving as a Member of Data Safety and Monitoring Board with National Institute Of Neurological Disorders And Stroke of the National Institutes of Health.
Shanna Patterson, MD, FAAN	Dr. Patterson has nothing to disclose.
Gabriel F. Baltazar	Dr. Baltazar has nothing to disclose.
Tuan H. Vu, MD	Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen (Horizon). Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Vu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from Mass Gen Hospital/Healy Platform Study. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Horizon/Amgen. The institution of Dr. Vu has received research support from Woolsey Pharma. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Johnson & Johnson. The institution of Dr. Vu has received research support from Immunovant. The institution of Dr. Vu has received research support from Regeneron. The institution of Dr. Vu has received research support from Dianthus. The institution of Dr. Vu has received research support from COUR.
Evan El-Halawani	Mr. El-Halawani has nothing to disclose.
Meredith Schultz, MD	Dr. Schultz has received personal compensation for serving as an employee of AskBio.
Shwetha Menon, MD	Dr. Menon has nothing to disclose.
Anna Shah, MD	The institution of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. The institution of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Shah has received research support from Rocky Mountain MS Center. The institution of Dr. Shah has received research support from Genentech/Roche. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ��al Speaker with Rocky Mountain MS Center.
Marina K. Alvim	Dr. Alvim has nothing to disclose.
Iffat Jabeen, MD	Dr. Jabeen has nothing to disclose.
Christina Istrate, MD	Dr. Istrate has nothing to disclose.
Rasha Aguzzi	Rasha Aguzzi has received personal compensation for serving as an employee of Alexion Pharmaceutical. Rasha Aguzzi has stock in AstraZeneca.
Yan Xu, MD, PhD	No disclosure on file
Mohammad Dibs, MD	Dr. Dibs has nothing to disclose.
Eldon Loh	No disclosure on file
Courtney Curran, MD	Dr. Curran has nothing to disclose.
Nathan P. Young, DO	Dr. Young has nothing to disclose.
Lucas S. Silva, MD	Dr. Silva has nothing to disclose.
George Park, DO	Dr. Park has nothing to disclose.
Mary Safaeipour, MD	Miss Safaeipour has nothing to disclose.
Glenn D. Graham, MD, PhD, FAAN	Dr. Graham has received personal compensation in the range of $10,000-$49,999 for serving as a Speaker with MER (non-profit CME provider). Dr. Graham has received personal compensation in the range of $500,000-$999,999 for serving as a Employee with Department of Veterans Affairs. An immediate family member of Dr. Graham has received personal compensation in the range of $100,000-$499,999 for serving as a Exployee with Department of Veterans Affairs.
Jared C. Wolfe, MD	Dr. Wolfe has nothing to disclose.
Linda S. Williams, MD, FAAN	The institution of Dr. Williams has received research support from VA HSR&D.
Narmada Mannem, MBBS	Dr. Mannem has nothing to disclose.
Ema Rodrigues, Other	Dr. Rodrigues has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Dr. Rodrigues has stock in Alexion Pharmaceuticals.
Timothy L. Vollmer, MD, FAAN	The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Kumaraswamy Sivakumar, MD, MRCP	Dr. Sivakumar has nothing to disclose.
Abby Bossart, MD	Dr. Bossart has nothing to disclose.
Andreas Schulte-Mecklenbeck	Andreas Schulte-Mecklenbeck has nothing to disclose.
Mordechai Z. Smith, MD	Dr. Smith has nothing to disclose.
Maurizio Facheris, MD, MSc	Dr. Facheris has received personal compensation for serving as an employee of Vanqua Bio. Dr. Facheris has stock in Vanqua Bio.
Sanjay N. Rakhade, MBBS, PhD	Dr. Rakhade has received personal compensation for serving as an employee of Alexion Pharmaceuticals . Dr. Rakhade has stock in Alexion Pharmaceuticals. Dr. Rakhade has stock in Astra Zeneca. Dr. Rakhade has received intellectual property interests from a discovery or technology relating to health care.
Yann Hyvert, PhD	Dr. Hyvert has received personal compensation for serving as an employee of The healthcare business of Merck KGaA, Darmstadt, Germany. An immediate family member of Dr. Hyvert has received personal compensation for serving as an employee of The healthcare business of Merck KGaA, Darmstadt, Germany.
Peter Ulrichts	Peter Ulrichts has received personal compensation for serving as an employee of argenx. Peter Ulrichts has stock in argenx.
Britney Barrera	Ms. Barrera has nothing to disclose.
Rajesh K. Gupta, MBBS	Dr. Gupta has nothing to disclose.
Niveta Aravind, MD	Dr. Aravind has nothing to disclose.
Jose R. Santos, MD	An immediate family member of Dr. Santos has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cochrane. Dr. Santos has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Giarmarco, Mullins & Horton PC. Dr. Santos has or had stock in Gilead Sciences.Dr. Santos has or had stock in Novocure.Dr. Santos has or had stock in Shockwave Medical.Dr. Santos has or had stock in Teva. An immediate family member of Dr. Santos has received research support from ��ɫ��. The institution of an immediate family member of Dr. Santos has received research support from Trinity Health Saint Mary's Foundation. An immediate family member of Dr. Santos has a non-compensated relationship as a Delegate with AAN Neurology on the Hill that is relevant to AAN interests or activities. An immediate family member of Dr. Santos has a non-compensated relationship as a Participant with AAN Palatucci Advocacy Leadership Forum that is relevant to AAN interests or activities. An immediate family member of Dr. Santos has a non-compensated relationship as a Scholar with AAN Health Equity Symposium Scholarship that is relevant to AAN interests or activities. An immediate family member of Dr. Santos has a non-compensated relationship as a Participant with AAN Emerging Leaders Program that is relevant to AAN interests or activities.
Kathryn Zuchowski, MD	Dr. Zuchowski has received personal compensation in the range of $500-$4,999 for serving as a QOD and Neuro SAE question writer with ��ɫ��.
Megan Amuan	No disclosure on file
Yaowei Zhu, PhD	Dr. Zhu has received personal compensation for serving as an employee of Johnson & Johnson.
Jeffrey A. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Angela L. Genge, MD	Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE. Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for eikonizo. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for rapa.
Renuka Verma	Renuka Verma has nothing to disclose.
Brian Werneburg	Mr. Werneburg has received personal compensation for serving as an employee of Stoke Therapeutics.
Nina Navalkar, MD	Dr. Navalkar has nothing to disclose.
Yessar M. Hussain, MD	The institution of Dr. Hussain has received research support from Alnylam Pharma.
Ralf Gold, MD	Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Cleo Zarina A. Reyes, MD	Dr. Reyes has nothing to disclose.
Samantha Anne Gutierrez, MD	Dr. Gutierrez has nothing to disclose.
Aaron S. Bower, MD	Dr. Bower has nothing to disclose.
Michal T. Gostkowski, DO	The institution of Dr. Gostkowski has received research support from Medtronic.
Tania Kuempfel, MD	Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon.
Anuradha Duleep, MD	Dr. Duleep has nothing to disclose.
Leonel Takada	No disclosure on file
Mark Vanderkelen	No disclosure on file
Carolina Barnett Tapia, MD	Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD pharma. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. The institution of Dr. Barnett Tapia has received research support from Department of defense. The institution of Dr. Barnett Tapia has received research support from Muscular dystrophy canada. The institution of Dr. Barnett Tapia has received research support from MgNet. The institution of Dr. Barnett Tapia has received research support from NIH. The institution of Dr. Barnett Tapia has received research support from Cartesian. The institution of Dr. Barnett Tapia has received research support from Alexion. Dr. Barnett Tapia has received intellectual property interests from a discovery or technology relating to health care.
Alexis Flowers	No disclosure on file
Lisa Eunyoung Lee	Lisa Eunyoung Lee has nothing to disclose.
Osvaldo J. Nascimento, MD, PhD, FAAN	Dr. Nascimento has nothing to disclose.
Pegah Masrori, MD	Dr. Masrori has received research support from European Academy of Neurology.
Gerd Meyer Zu Horste, MD	Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant, Argenx, Johnson&Johnson. Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen, Argenx, Sanofi. The institution of Dr. Meyer Zu Horste has received research support from Roche. Dr. Meyer Zu Horste has received intellectual property interests from a discovery or technology relating to health care.
Gitanjali Das, MD	Dr. Das has nothing to disclose.
Alain Lamontagne, PhD	Dr. Lamontagne has received personal compensation for serving as an employee of Asklepios Biopharmaceutical Inc.
Umair Azhar	Mr. Azhar has nothing to disclose.
Maryellen Campbell, MD	Dr. Campbell has nothing to disclose.
Timothy Lesnick	No disclosure on file
Marie-Helene Jouvin	Marie-Helene Jouvin has received personal compensation for serving as an employee of Fulcrum Therapeutics. Marie-Helene Jouvin has received personal compensation for serving as an employee of Pharvaris. Marie-Helene Jouvin has stock in Fulcrum Therapeutics. Marie-Helene Jouvin has stock in Pharvaris.
Miriam L. Freimer, MD, FAAN	Dr. Freimer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for J and J. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Freimer has received research support from Alnylum. The institution of Dr. Freimer has received research support from UCB. The institution of Dr. Freimer has received research support from NIH. The institution of Dr. Freimer has received research support from Janssen. Dr. Freimer has received research support from Avidity. Dr. Freimer has received research support from Fulcrum. The institution of Dr. Freimer has received research support from Dept of defense. The institution of an immediate family member of Dr. Freimer has received research support from Abcurro. Dr. Freimer has received personal compensation in the range of $10,000-$49,999 for serving as a presentations/teaching with UCB.
Ashley Young	Miss Young has nothing to disclose.
Arthur Simen	Arthur Simen has received personal compensation for serving as an employee of Takeda.
Soroush Kakawand, MD	Dr. Kakawand has nothing to disclose.
Nakul Katyal, MD	Dr. Katyal has nothing to disclose.
Sania Azhar	Ms. Azhar has nothing to disclose.
Marina Solti, MD	Dr. Solti has nothing to disclose.
Tobias Moser	Mr. Moser has nothing to disclose.
Andrew J. Gordon, MD	Dr. Gordon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion . Dr. Gordon has received personal compensation in the range of $0-$499 for serving as a Consultant for Vertex. Dr. Gordon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Gordon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Gordon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cassiday.
Nathaniel P. Rogers, Jr., MD	Dr. Rogers has nothing to disclose.
Robert Flinn, MD	Dr. Flinn has nothing to disclose.
Matthias Goebeler	No disclosure on file
Karissa Gable, MD, FAAN	Dr. Gable has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Accordant. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Gable has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazenca. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols . Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for annexon. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Julian Gal, MD, MA	Dr. Gal has nothing to disclose.
Marco M. Wolmarans, MD	Mr. Wolmarans has nothing to disclose.
Stephan Ortiz, PhD	Dr. Ortiz has received personal compensation for serving as an employee of Alexion/AstraZeneca Rare Disease. Dr. Ortiz has stock in Alexion.
Kasun I. Navarathna, MD	Dr. Navarathna has nothing to disclose.
Sakinah Sabadia, MD	Dr. Sabadia has nothing to disclose.
Bichun Ouyang	Bichum Ouyang has nothing to disclose.
Jeremias Motte, MD	The institution of Prof. Motte has received research support from Ruhr-Univerity Bochum.
Manik Tetarbe, MD	Dr. Tetarbe has nothing to disclose.
Trilok Stead	Trilok Stead has nothing to disclose.
Edward Brauer	Edward Brauer has received personal compensation for serving as an employee of argenx. Edward Brauer has stock in argenx.
Sailaja Sanikommu, MBBS	Dr. Sanikommu has nothing to disclose.
Pooja Gupta, MD	Dr. Gupta has nothing to disclose.
Saranya Gomathy	No disclosure on file
Gianvito Masi, MD	Dr. Masi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen.
Jan L. De Bleecker, MD, PhD, FAAN	Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgNX. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. De Bleecker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharmaceuticals. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro.
Syed Omar Shah, MD	Dr. Shah has nothing to disclose.
Nigar Dargah-Zada, MD	Dr. Dargah-Zada has nothing to disclose.
Rajinder K. Dhamija, MD, FRACP	Prof. Dhamija has nothing to disclose.
Alexandra R. Santana Almansa, MD	Dr. Santana Almansa has nothing to disclose.
Michael A. Perez, MD	Dr. Perez has nothing to disclose.
Azizi Seixas	No disclosure on file
Jieun Kang, MD	Dr. Kang has nothing to disclose.
Shahram Izadyar, MD, FAAN	The institution of Dr. Izadyar has received research support from Xenon Pharmaceuticals. An immediate family member of Dr. Izadyar has received publishing royalties from a publication relating to health care.
Nirav Pavasia, MD	Dr. Pavasia has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Pavasia has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Pavasia has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Pavasia has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. Dr. Pavasia has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Mariam a. Al Hussona, MB BCh BAO	Dr. Al Hussona has nothing to disclose.
Mohamed Afify, MD	Dr. Afify has nothing to disclose.
Michael K. Hehir II, MD	Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Hehir has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Hehir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Hehir has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum- ��ɫ��. Dr. Hehir has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. The institution of Dr. Hehir has received research support from Myasthenia Gravis Foundation of America. The institution of Dr. Hehir has received research support from University of Vermont Medical Center.
Chelsea Schmoll, DO	Dr. Schmoll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . Dr. Schmoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Schmoll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Abhilash Thatikala, MD, MBBS, DM	Dr. Thatikala has nothing to disclose.
Ryan Hays, MD, MBA, FAES, FAAN	Dr. Hays has nothing to disclose.
Robert S. Raike, PhD	Dr. Raike has received personal compensation for serving as an employee of Medtronic. Dr. Raike has received intellectual property interests from a discovery or technology relating to health care.
Karen Halldorsdottir, MD	Dr. Halldorsdottir has nothing to disclose.
Matthew Vibbert, MD	Dr. Vibbert has nothing to disclose.
Lucienne Costa C. Franca, Sr., PhD	Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Almirall. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biopas. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristoll-Mayer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Scott Stanslaski	Scott Stanslaski has received personal compensation for serving as an employee of Medtronic. Scott Stanslaski has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Medtronic. Scott Stanslaski has stock in Medtronic. Scott Stanslaski has received intellectual property interests from a discovery or technology relating to health care. Scott Stanslaski has received personal compensation in the range of $100,000-$499,999 for serving as a Engineer with Medtronic.
Diego Silva	Diego Silva has received personal compensation for serving as an employee of BMS. Diego Silva has received stock or an ownership interest from BMS.
Irena Dujmovic Basuroski, MD, PhD	The institution of Dr. Dujmovic Basuroski has received research support from Alexion Pharmaceuticals, Inc. The institution of Dr. Dujmovic Basuroski has received research support from Biogen MA Inc. The institution of Dr. Dujmovic Basuroski has received research support from EMD Serono Research and Development Institute, Inc . The institution of Dr. Dujmovic Basuroski has received research support from Celgene Corporation/Bristol-Myers Squibb. The institution of Dr. Dujmovic Basuroski has received research support from The Bodford Family Transverse Myelitis Center Fund. The institution of Dr. Dujmovic Basuroski has received research support from CorEvitas, LLC. The institution of Dr. Dujmovic Basuroski has received research support from Novartis. The institution of Dr. Dujmovic Basuroski has received research support from Ad Scientiam. Dr. Dujmovic Basuroski has received personal compensation in the range of $0-$499 for serving as a Travel -related expenses to attend clinical trial investigator meeting with Novartis. Dr. Dujmovic Basuroski has received personal compensation in the range of $500-$4,999 for serving as a International Clinical Consortium Member, Travel -related expenses to attend the meeting with The Guthy-Jackson Charitable Foundation.
Judith Bellmann-Strobl, MD	Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Judith Bellmann-Strobl, MD has received research support from Bayer. The institution of Judith Bellmann-Strobl, MD has received research support from NEMOS.
Marzena Pedrini, PhD	Dr. Pedrini has nothing to disclose.
Eric Stulberg, MD	Dr. Stulberg has nothing to disclose.
Julian Thomas, MD	Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scholar Rock. Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Thomas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ITF Therapeutics. Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Thomas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Robert A. Hauser, MD, MBA, FAAN	Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Prashanthi Vemuri, PhD	The institution of Dr. Vemuri has received research support from NIH.
Ali A. Habib, MD	Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NMD Pharma. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/ Amgen. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jansen/Johnson & Johnson. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMDSerono/Merck. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunis Biomedical. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman-La Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jansen/Joohnson & Johnson. The institution of Dr. Habib has received research support from Alexion. The institution of Dr. Habib has received research support from Horizon/Amgen. The institution of Dr. Habib has received research support from Immunovant. The institution of Dr. Habib has received research support from UCB. The institution of Dr. Habib has received research support from argenx. The institution of Dr. Habib has received research support from CabalettaBio. The institution of Dr. Habib has received research support from Regeneron. The institution of Dr. Habib has received research support from Arcellx. The institution of Dr. Habib has received research support from Novartis. The institution of Dr. Habib has received research support from EMDSerono/Merck. The institution of Dr. Habib has received research support from Cour Pharmaceuticals.
Leona Ling, PhD	Dr. Ling has received personal compensation for serving as an employee of Janssen Pharmaceuticals (Johnson&Johnson). Dr. Ling has stock in Janssen Pharmaceuticals (Johnson&Johnson). Dr. Ling has received intellectual property interests from a discovery or technology relating to health care. Dr. Ling has received intellectual property interests from a discovery or technology relating to health care.
Timothy Lim	No disclosure on file
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Caleb Pearson, PhD	Dr. Pearson has received publishing royalties from a publication relating to health care.
Humay Ismayilzada III, MD	Mr. Ismayilzada has nothing to disclose.
Luisa M. Villar	Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers Squibb. The institution of Luisa M. Villar has received research support from European Union. The institution of Luisa M. Villar has received research support from Instituto de Salud Carlos III (Spanish Goverment).
Michael Pomfret	No disclosure on file
Adel Hijazi, MD	Mr. Hijazi has nothing to disclose.
Matthew Gusler, DO	Dr. Gusler has nothing to disclose.
Alexander Doyle, MD	Dr. Doyle has nothing to disclose.
Karan Patel, MD	Mr. Patel has nothing to disclose.
Rohan Sharma, MD	Dr. Sharma has nothing to disclose.
Nicholas Yelverton, DO	Dr. Yelverton has nothing to disclose.
Houari Korideck, MD	Dr. Korideck has nothing to disclose.
Jasmine Parihar, DM	Dr. Parihar has nothing to disclose.
Christopher D. Lee, MD	Dr. Lee has nothing to disclose.
Solomon Oak, MD	Mr. Oak has nothing to disclose.
Catherine Broome	No disclosure on file
Davorka Tomic	Davorka Tomic has stock in Meck KGaA.
Nicholas Karagas, MD	An immediate family member of Dr. Karagas has received personal compensation for serving as an employee of Thirty Madison. An immediate family member of Dr. Karagas has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Thirty Madison. An immediate family member of Dr. Karagas has stock in Thirty Madison.
Marc A. Swerdloff, MD	Dr. Swerdloff has nothing to disclose.
Nathaniel G. Wooten, MD	Dr. Wooten has nothing to disclose.
Achal K. Srivastava, MD, FAAN	Dr. Srivastava has nothing to disclose.
Ke Li, MD	Dr. Li has nothing to disclose.
Jessika Suescun, MD	Dr. Suescun has nothing to disclose.
Joel E. Kleinman, MD, PhD	Dr. Kleinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Kleinman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Austin Sidley law Firm.
Baukje Bijnens	An immediate family member of Miss Bijnens has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundbeck . The institution of Miss Bijnens has received research support from University of Antwerp .
Ronak U. Trivedi	Mr. Trivedi has nothing to disclose.
Victor M. Torres-Lopez, MA	Mr. Torres-Lopez has nothing to disclose.
Kyle T. Mitchell, MD	Dr. Mitchell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Mitchell has received research support from Medtronic. The institution of Dr. Mitchell has received research support from Deep Brain Innovations. The institution of Dr. Mitchell has received research support from National Institutes of Health. The institution of Dr. Mitchell has received research support from National Institute on Aging.
Rita Elias, DO	Dr. Elias has nothing to disclose.
Gary R. Cutter, PhD	Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Reshma B. Shahzadi, MBBS	Dr. Shahzadi has nothing to disclose.
Sara W. Hyman	Ms. Hyman has nothing to disclose.
Philip Van Damme	The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for QurAlis. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for VectorY. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NRG Therapeutics. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van Damme has received research support from CSL Behring.
Ayush Agarwal, DM	Dr. Agarwal has nothing to disclose.
Maria I. Leite, MD	The institution of Dr. Leite has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon / Amgen. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela/Horizon/Amgen. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Leite has received research support from Non-Profit Organization - Myaware. The institution of Dr. Leite has received research support from UCB - Ra Pharma. The institution of Dr. Leite has received research support from Non-Profit Organization - Muscular Dystrophy UK.
Alyssa Carlson	Ms. Carlson has nothing to disclose.
Lorne H. Zinman, MD	Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, MTP, AB Science, Cytokinetics, Amylyx. Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx.
Xavier Montalban, MD, PhD, FAAN	The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Koroboshka Brand-Arzamendi	No disclosure on file
Su Jung Choi, PhD, RN	Ms. Choi has nothing to disclose.
Pascal Benkert	Pascal Benkert has nothing to disclose.
Muhammad S. Bhatti, MD	Dr. Bhatti has nothing to disclose.
Gabriela Alejo, MD	Dr. Alejo has nothing to disclose.
Fatai M. Akemokwe, MBBS	Dr. Akemokwe has stock in CVS HEALTH CORP. Dr. Akemokwe has stock in LABORATORY CORP AMERICAN HOLDINGS.
Mark I. Boulos, MD, FRCPC, CSCN(EEG), MSc	Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision AQ. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sleep Medicine (journal). The institution of Dr. Boulos has received research support from Canadian Institutes of Health Research. The institution of Dr. Boulos has received research support from Slamen-Fast New Initiatives in Neurology Award. The institution of Dr. Boulos has received research support from Green Mountain . The institution of Dr. Boulos has received research support from RLS Foundation. The institution of Dr. Boulos has received research support from Temerty Centre for AI Research and ��ɫ�� in Medicine (T-CAIREM). The institution of Dr. Boulos has received research support from Heart & Stroke Foundation of Canada. The institution of Dr. Boulos has received research support from Alternative Funding Plan from the Academic Health Sciences Centres of Ontario. The institution of Dr. Boulos has received research support from StrokeCog. The institution of Dr. Boulos has received research support from McLaughlin Centre for Molecular Medicine . Dr. Boulos has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Jazz Pharmaceuticals.
Patrick J. Lavin, MB, BCh	Dr. Lavin has nothing to disclose.
George Li, MD	Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RemeGen bioscience .
Allan G. Kermode, MD, MBBS, FRACP	Dr. Kermode has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kermode has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche.
Timothy M. Ellmore, PhD	Prof. Ellmore has nothing to disclose.
Amrita Pandey, MD	Dr. Pandey has nothing to disclose.
Natasha Thomas	Miss Thomas has nothing to disclose.
Sayyeda Zahra, MD	Dr. Zahra has nothing to disclose.
Matthew Rosebraugh, PhD	Dr. Rosebraugh has received personal compensation for serving as an employee of AbbVie Inc. Dr. Rosebraugh has stock in AbbVie Inc..
Nadia Sial, MD	Ms. Sial has nothing to disclose.
Victor W. Sung, MD	Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Neuroscience. Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Sung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure.
Nandakumar Narayanan, MD, PhD	Dr. Narayanan has nothing to disclose.
Muhammed Ors	Mr. Ors has nothing to disclose.
Ye Su, DO	Dr. Su has nothing to disclose.
Simon Laganiere, MD	Dr. Laganiere has nothing to disclose.
Shaheen Sombans, MBBS	Dr. Sombans has nothing to disclose.
Stefanie J. Rodenbeck, MD	Dr. Rodenbeck has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Katrina Anderson	Katrina Anderson has nothing to disclose.
Sherry Fung	Ms. Fung has nothing to disclose.
Rafael Joao	Mr. Joao has nothing to disclose.
Shima Zargar, MD	Dr. Zargar has nothing to disclose.
Nily Osman, MD	No disclosure on file
Nayla Chaijale	Nayla Chaijale has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Wilgee Eila S. Abbot, MD	Dr. Abbot has nothing to disclose.
Christian Wichmann	Dr. Wichmann has received personal compensation for serving as an employee of Novo Nordisk.

��ɫ����

��ɫ����

��ɫ��

��ɫ��